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ABSTRACT
Brief Assessment of Distress and Pain
Laura L. Quentin
Pain has been conceptualized as a mixture of physical and psychological factors that are
indicative of actual or potential damage to one’s physical being. The experience of pain is a
complex interaction of somatic, behavioral, affective, and cognitive components. Of particular
interest is the growing body of literature regarding the roles that negative psychological states
such as anxiety, fear, and depression have in the contribution of poorer outcomes for individuals
suffering from painful conditions. Specifically, these psychological concerns can exacerbate the
overall experience of pain and lead to higher rates of dysfunction and disability. Given the
importance of these variables, there is a need for an efficient assessment of them in relation to
pain. The present investigation focused on the development of a brief (i.e., 4-item scale) to assess
fear, anxiety, depression, and overall negative affectivity in relation to the experience of pain.
The study incorporated a multi-level developmental process inclusive of the use of expert judges,
an undergraduate student sample (n = 415), and a heterogeneous chronic pain sample (n = 45).
Principal components analyses indicated that the BADP consisted of one factor; inter-scale
correlation coefficients revealed that the BADP was highly related to other measures that assess
similar constructs. Intra-scale correlation coefficients indicated that the subscales of the Brief
Assessment of Distress and Pain were moderately associated with each other. These data suggest
the BADP is a good measure of negative affectivity related to pain. The BADP displays utility in
multiple samples and is suitable for further clinical study.
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Brief Assessment of Distress and Pain
Pain and emotion are intricately intertwined. Pain can be an important and helpful state,
but chronic pain and its emotional components is a significant problem. Research consistently
has indicated that anxiety, fear, and depression are highly related to the experience of pain and
the effectiveness of treatment of pain-related conditions. Anxiety, fear, and depression, in
combination with the experience of chronic pain, lead to greater impairment, disability, and
poorer outcomes. Due to the high rate of comorbidity of pain and these psychological states, as
well as the importance of associated negative outcomes, it is vital to develop assessment
instruments in this area, in hopes of improving quality of life and treatment methodologies.
While there are existing approaches to assessing negative affect associated with pain, the length
of the instruments makes them impractical in in many clinical settings. Therefore, there is a need
for a brief assessment which addresses negative affect, anxiety, fear, and depression, focusing on
their association with pain, in one inclusive scale. In light of this aspiration and lack of a brief
scale with general, over-arching items that address these psychological constructs and pain, the
intent is to develop a brief scale that will examine emotional distress associated with pain.
Specifically, the brief scale will assess depression, anxiety, and fear in relation to the experience
of pain directly. The ultimate goal is for this brief scale to be able to stand alone as an effective
and reliable assessment for identifying individuals suffering from the experience of pain and
comorbid psychological states. This assessment would be applicable in clinical settings to
identify individuals who may suffer from anxiety, fear, or depression with pain in hopes of
improving treatment. In addition to the following introduction, Appendix A contains a
comprehensive review of the literature.
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Interaction of Pain and Other Psychological States
A significant portion of pain conditions have been found to be etiologically less directly
related to physical ailments and more characteristic of psychological variables such as anxiety,
anxiety sensitivity, fear, and catastrophizing cognitions (Carelton et al., 2009). These
psychological variables have been found to influence the onset, duration, and intensity of pain, as
well as to exacerbate its physical sensations (Beesdo et al., 2010). In fact, these psychological
states also have been found to negatively affect patient responses to pain treatment (Keen, Rea,
& Aldington, 2011). Treatment of anxiety and fear also may be potentially effective in the
reduction of pain (Asmundson, Norton, & Norton, 1999). Pain also can negatively affect the
psychological functioning of patients with chronic pain (Keene et al., 2011). The experience of
pain can predispose individuals to develop hypervigiliance, which is associated with fear,
anxiety, sleep deficits, and learned helplessness (Keene et al., 2011). Specifically, chronic pain
also has been found to be comorbid with depression (Cleeland, 1986; Karoly et al., 2008;
Poleshuck et al., 2010). In fact, the experience of pain over time can predispose individuals to
the development of anxiety and depression (Eken et al., 2010). This phenomenon, however, does
not always occur in a sequential order. Pain, anxiety, and depression may develop at similar
points in time, or may predate one another. In addition to the development of anxiety and
depression, the continued experience of pain over time can lead to avoidance behaviors and
decreased quality of life (Karoly et al., 2008; Skevington, 1998).
Conceptualizations of Anxiety, Fear, and Pain
The view of the relations among anxiety, fear, and pain has changed over time. Initially,
pain and fear were viewed as completely separate constructs with no common overlap (McNeil
& van Wijk, 2005). As research advanced, experts within the field began to view the relationship
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between fear and pain as unidirectional (McNeil & van Wijk, 2005). Specifically, fear was
conceptualized as having a direct impact on the experience of pain (McNeil & van Wijk, 2005).
This conceptualization is evident with the development of the Gate-Control Theory, which
focuses on fear and other negative emotional states as being a factor for contributing to a more
debilitating experience associated with pain (Melzack & Wall, 1965). Bolles and Fanselow
(1980) later developed the Perceptual-Defensive-Recuperative theory. This theory, which is
based on evolutionary principles, posited fear and pain as competing forces rather than as
interacting in a compound nature. Bolles and Fanselow (1980) believed that fear and pain inhibit
the expression of the other state. Later, experts began to believe that fear and pain were in fact
highly correlated and shared similarities of expression (McNeil & van Wijk, 2005). The current
model involves an interaction between not only fear and pain, but also anxiety. Specifically, fear,
anxiety, and pain are viewed as mutually interacting with each other, thus affecting the
expression and behavior associated with the experience of pain (McNeil & van Wijk, 2005). It is
this model that will be used as a basis for developing a brief assessment, which will examine the
constructs of pain, anxiety, fear, and depression.
Overall, fear, anxiety, depression, and overall negative affectivity all are related to the
experience of pain and have been shown to exacerbate the experience of pain. The associations
between these emotional states and pain are not necessarily linear in nature. The associations
among fear, anxiety, depression, overall negative affectivity, and pain are multi-directional and
complex. In general however, negative emotional states, in combination with chronic pain, lead
to greater disability, functional impairment, and poorer health outcomes.
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Statement of the Problem
Numerous assessment instruments have been developed to evaluate relations among fear,
anxiety, and pain including Fear of Pain Questionnaire-III (FPQ-III), Pain Anxiety Symptoms
Scale (PASS), Fear-Avoidance Beliefs Questionnaire (FABQ), and Tampa Scale for
Kinesiophobia (TSK-11) (McCraken, Zayfert, & Gross, 1992; McNeil & Rainwater, 1998;
Wadell, Newton, Henderson, Somerville, & Main, 1993; Woby, Roach, Urmston, & Watson,
2005). These measures have intermixed the constructs of fear and anxiety, failing to differentiate
between them and pain. In addition, other important emotional states that are commonly
associated with pain, such as depression, have been neglected. These limitations highlight the
need for an assessment that measures common affective states in relation to pain. Additionally,
assessing overall negative affect as a general construct may be fruitful in relation to the study of
emotion and pain. This gap in the literature highlights the need for a short assessment scale
which will evaluate depression, fear, and anxiety, in relation to the experience of pain. Currently,
no scale exists that assesses all three of these constructs together relative to pain. The
development of a short assessment that examines negative emotional states and pain may assist
in the early detection of individuals with comorbid conditions.
In healthcare settings, the length and scoring demands of a screening or other assessment are
crucial in relation to utility (Krebs et al., 2009). Due to the length of these self-report measures,
many are not incorporated into standard protocols in healthcare settings (Krebs et al., 2009).
Longer assessments tend to have poorer response rates which can lead to inaccurate statistical
conclusions relating to the constructs of interest (Faragher, Cooper, & Cartwright, 2004). Shorter
instruments, however, can be easily implemented into busy, fast-paced healthcare settings in
which time of both the patient and staff is of the concern. A brief assessment is less likely to
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burden the patient taking the assessment, and the staff who must score and analyze the results. A
short measure can serve as a useful and practical screener to identify individuals who may be at
greater risk for comorbid conditions thus leading to improved treatment and referrals to
appropriate providers.
There are several issues that should be considered when constructing a short assessment. The
length of an instrument can directly affect the reliability of the scale such that longer assessments
tend to be more valid than short assessments (Furr & Bacharach, 2008). Some argue that single
item assessments may be less sensitive, but through careful examination and analysis, can still be
valid (Bowling, 2005). Shorter assessments have been found to possess greater validity than
lengthier assessments (Bowling, 2005). Single item assessments with adequate reliability and
validity have been tested and incorporated in multiple health-based surveys (Bowling, 2005).
Several scales (i.e., Visual Analogue Scale and single item quality of life assessment) have been
found to possess strong psychometric properties and are widely utilized (Bowling, 2005).
Advantages of single item scales include simplicity and decreased burden on the participants
(Bowling, 2005). Omnibus items on short assessments can be criticized for being less sensitive,
but these items can be highly valid.
The major goal of this study is to create a short scale which assesses each of the three
constructs (fear, anxiety, and depression) in relation to the experience of pain, and has an overall,
omnibus item which would be representative of overall negative affectivity towards the
experience of pain. The availability of such an assessment would ease the administration process
as well as the scoring procedure, positively impacting both clinicians and patients. Overall
implications of the development of this type of instrument include identification of at risk
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individuals in health-care settings, which may lead to improved preventive treatment and
treatment methodologies.
Method
Participants
Individuals in this study were 500 introductory Psychology undergraduate students at
West Virginia University and 60 patients seeking treatment for a variety of pain related
conditions at a pain clinic in Winston-Salem, NC. Sample sizes were based on recommendations
by Costello and Osborne (2005) and Lingard and Rowlinson (2005). The recommendations
indicate a 10:1 ratio of participants to items is sufficient to produce correct solutions. The
inclusion criterion specified that all participants must be 18 years of age or older and must be
able to read, write, and comprehend the English language. Exclusion criteria included the
presence of psychotic symptomatology or a pervasive developmental disorder. Procedures
adhered to American Psychological Association ethical guidelines for the proper treatment of
human subjects, as well as the informed consent process and approval of the research by the
Institutional Review Board at West Virginia University.
Measures
Fear of Pain Questionnaire-III. The FPQ-III is a measure that assesses fear of pain
(McNeil & Rainwater, 1998). The instrument consists of 30 items which examine three domains
of pain: Minor, Medical, and Severe pain (McNeil & Rainwater, 1998). Items are scored on a 5
point Likert type scale ranging from 1 = Not at all to 5 = Extreme (McNeil & Rainwater, 1998).
Items are scored by summing subscales scores (McNeil & Rainwater, 1998). The FPQ-III
possesses high test-retest reliability (r = .92) and high internal consistency (α = .74) (McNeil &
Rainwater, 1998). Each subscale also possesses high internal consistency, Severe Pain (α = .88),
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Minor Pain (α = .87), and Medical Pain (α = .87), and strong test-retest correlations (.69 < r <
.76) indicating stability over time (McNeil & Rainwater, 1998); please refer to Appendix C.
Pain Anxiety Symptoms Scale. The PASS assesses the experience of fear and anxiety in
relation to the experience of pain (McCraken et al., 1992). The measure consists of 21 items
which assess four domains of fear and anxiety and their relationship to pain: Somatic Anxiety,
Cognitive Anxiety, Fear, and Escape or Avoidance (McCraken et al., 1992). Items are scored on
a 6 point Likert type scale ranging from 0 = Never to 5 = Always (McCraken et al., 1992). Items
are summed for a total score indicative of overall fear/anxiety in relation to pain (McCraken et
al., 1992). The overall measure possesses high internal consistency (α = .94) (McCraken et al.,
1992). Subscales also are summed for a specific indication of degree of anxiety or fear
(McCraken et al., 1992). Each subscale also possesses high internal consistency, Somatic
Anxiety (α = .89), Cognitive Anxiety (α = .87), Fear (α = .85), and Escape or Avoidance (α =
.81) (McCraken et al., 1992). As reported by McCraken et al. (1992), the PASS was found to
have sound concurrent validity in comparison to the Beck Depression Inventory (r = .57), the
Multidimensional Pain Inventory (.32 < r < .39), and the Pain Disability Index (r = .45) for
patient outcome variables such as disability and depression; please refer to Appendix D.
Beck Depression Inventory-II (BDI-II). This scale is a predominant instrument for
assessing overall severity of depression (Anastopoulos & Shelton, 2001; Beck, Steer, & Brown,
1996). The BDI-II is the updated revision of the original BDI (Anastopoulos & Shelton, 2001;
Beck et al., 1996). The BDI-II is a self-report instrument that contains 21 items on a 4 point
Likert type scale (Anastopoulos & Shelton, 2001; Beck et al., 1996). The BDI-II matches well to
the DSM-IV-TR criteria which assess the cognitive, somatic, and affective components of
depression (Anastopoulos & Shelton, 2001; Beck et al., 1996). The two subscales that compose
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the BDI-II are the Cognitive-Affective factor and the Somatic factor (Beck et al., 1996; Storch,
Roberti, & Roth, 2004). The BDI-II has sound psychometric properties in addition to being easy
to administer and score (Anastopoulos & Shelton, 2001; Beck et al., 1996). The BDI-II had
strong test-retest reliability (.74 < r < .96) in a student client sample, outpatient sample, and
hearing impaired sample (Sprinkle et al., 2002). The BDI-II also has high internal consistency (r
< .90). Each subscale also possesses high internal consistency, Cognitive-Affective factor (r <
.87) and the Somatic factor (r < .74) (Storch et al., 2004). The BDI-II also has strong convergent
validity with the BDI (.84 < r < .93), the Hamilton Psychiatric Rating Scale for Depression, the
Beck Hopelessness Scale (.68 < r < .71), the Speilberger’s State Trait Anxiety Inventory Anxiety
factor (.52 < r < .69), and the Speilberger’s State Trait Anxiety Inventory Depression factor (.57
< r < .76) (Sprinkle et al., 2002; Storch et al., 2004). The BDI-II is not included in the
appendices due to copyright restrictions.
Anxiety Sensitivity Index-3. The ASI-3 assesses a high order factor of anxiety sensitivity
(Taylor et al., 2007). The higher order factor of anxiety sensitivity is composed of 3 lower order
factors which are cognitive, social, and physiological concerns (Taylor et al., 2007). The ASI-3
consists of 18 items which are scored on a 5 point Likert type scale (0 = very little to 4 = very
much) (Taylor et al., 2007). The internal consistency of the ASI-3 is moderate to high (.73 < α <
.91) (Taylor et al., 2007). The ASI-3 also has been shown to have adequate convergent,
discriminant, and criterion-related validity (Taylor et al., 2007); please refer to Appendix E.
Tampa Scale for Kinesiophobia-11. The TSK-11 assesses the pain related fear of
movement of re-injury in chronic back pain patients (Woby et al., 2005). It is the shortened
version of the original Tampa Scale for Kinesiophobia (Woby et al., 2005). The TSK-11 is an 11
item measure that is scored on a 4 point Likert type scale ranging from strongly disagree to
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strongly agree (Woby et al., 2005). Higher scores on the TSK-11 are indicative of greater fear of
movement or re-injury (Woby et al., 2005). The TSK-11 has moderate to high internal
consistency (α = .79) (Woby et al., 2005). The TSK-11 also demonstrates high test-retest
reliability (r = .82) as depicted by intraclass correlation analyses (Woby et al., 2005). The TSK11 also has construct, concurrent, and predictive validity (Woby et al., 2005). Reductions in the
scores on both the TSK and TSK-11 were associated with reductions in overall disability in
chronic lower back pain sufferers (Woby et al., 2005). The TSK-11 has been found to be
comparable to the original TSK (r = .93) (Woby et al., 2005). The TSK-11 instructions were
altered to make them more applicable to an undergraduate student sample; please refer to
Appendix F.
Fear-Avoidance Beliefs Questionnaire. The FABQ assesses individuals’ beliefs about how
work related tasks and physical activity affected their degree of pain (Waddell et al., 1993). The
FABQ focuses on the degree to which an individual reports fear of an activity and avoids it,
which has been associated with work related losses and decreased physical activity (Waddell et
al., 1993). The FABQ has two factors, fear-avoidance beliefs related to back pain and work and
fear-avoidance beliefs about general physical activity (Waddell et al., 1993). The FABQ is a 16
item self-report assessment that is scored on a 7 point Likert type scale ranging from strongly
disagree to strongly agree (Waddell et al., 1993). The FABQ demonstrates strong test-retest
reliability (.88 < r < .95) over a 48 hour testing period (Waddell et al., 1993). In a sample of 184
lower back pain patients, the two factors on the FABQ the fear-avoidance beliefs relating to
work and the fear-avoidance beliefs about physical activity scale accounted for 26% of the
variance associated with loss of work, 23% of the variance of disability after controlling for pain

10
BRIEF ASSESSMENT OF DISTRESS AND PAIN
severity (Waddell et al., 1993). The FABQ instructions were altered to make them more
applicable to an undergraduate student sample; please refer to Appendix G.
Fear Questionnaire. The FQ is a 17 item self-report measure that assesses the degree of
severity of several anxiety-related phobias (Marks & Mathews, 1979). A few of the phobias
assessed on the FQ are agoraphobia and social phobia (Marks & Mathews, 1979). The FQ is
scored on a 9 point Likert type scale (0 = Would not avoid it to 8 = Always avoid it) (Marks &
Mathews, 1979). For this study, the agoraphobic scale was utilized to determine divergent
validity from the Brief Assessment of Distress and Pain. The agoraphobia scale (Ag) of the FQ
ranges from a score of 0 to 40 (Marks & Mathews, 1979). The internal consistency of
agoraphobia scale of the FQ is moderate to high (.71 < α < .83) in a sample of participants with
diagnosed anxiety disorders (Marks & Mathews, 1979). The FQ-AG was included only in the
undergraduate assessment battery to examine the discriminant validity between the FQ-AG and
the BADP; please refer to Appendix H.
Demographic and Health Questionnaire. This instrument asked for participants’ sex, age,
ethnicity, social economic status, education level, employment status, and income. In addition,
the demographic questionnaire asked for participants’ presence of pain, severity of pain,
pertinent physical injuries or illnesses (e.g., broken bones, surgeries, sprains, migraines), current
psychotropic, narcotic or anti-inflammatory medication usage, and past experiences of severe or
chronic pain, significant injuries, and childbirth. A general health item from the Health SurveyShort Form was included in the demographic questionnaire for the pain sample (Ware, Kosinski,
& Keller, 1996); please refer to Appendices I and J.
Reliability items. There were four items added to the assessment battery for the
undergraduate sample (J. Patrick, personal communication, March, 2013). These types of items

11
BRIEF ASSESSMENT OF DISTRESS AND PAIN
have been incorporated in previous studies on SONA. These items were included to check that
each participant was adequately reading and reporting to the items that composed the assessment
battery; please refer to Appendix K.
Procedure
Initial scale development. Construct definitions for anxiety, fear, depression, negative
affect, and pain were developed by members (i.e., one faculty member, five graduate students,
and three undergraduate students) of the Anxiety, Physiology, and Pain research laboratory
(APPL) at West Virginia University. Items also were designed, critiqued, and analyzed in APPL
laboratory. These definitions were based on previous definitions in the literature and expert
opinion. Academics, health, and mental health professionals (n = 11) who specialize in the field
of emotion and pain were selected to serve as expert judges based on the criteria outlined by
DeVellis (2003). The list of expert judges that were selected and asked to participate in the
development of the BADP was generated in the APPL laboratory. If the judge agreed to
participate, he or she was provided with an operational definition of each construct and the item
pool, please refer to Appendix B. Expert judges rated each item as essential, useful but not
essential, or not necessary based on the criteria outline by Lawshe (1975).
After feedback from the expert judges, the best items were selected for each construct
comprising the Brief Assessment of Distress about Pain scale. A total of 20 items was retained
for the version of the BADP that was administered to the undergraduate sample and the pain
sample. Readability was assessed through the Flesch-Kincaid readability tests (i.e., readability
ease and grade level) to ensure that the reading level is at a sixth grade level or below. The
Flesch-Kincaid readability tests examine choice of words, length of sentences, and sentence
structure to determine the overall comprehension level required to understand the content of the
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assessment, and assigns a grade level to the document (Kincaid, Fishburne, Rogers, & Chissom,
1975).
Testing with the undergraduate sample. Undergraduate participants from a variety of
Psychology courses in the present study were volunteers who were recruited through
advertisements within the Psychology Department at West Virginia University. All participants
gave written informed consent, completed a demographic questionnaire, and a battery of
assessments inclusive of the Brief Assessment of Distress about Pain.
The undergraduate sample was administered a 20 item version of the Brief Assessment of
Distress and Pain scale. The undergraduate sample (N = 500) was administered the demographic
questionnaire and the battery of assessments on a computer through SONA, a web-based online
survey system which has a licensed contract with West Virginia University. The battery of
assessments included the FPQ-III, PASS, BADP, BDI-II, ASI-3, TSK-11, FQ-AG, demographic
questionnaire, and the FABQ which were presented in the order listed.
Testing with the chronic pain sample. A sample of 60 chronic pain patients also was
recruited on a volunteer basis in a pain clinic in Winston-Salem, North Carolina. The purpose of
incorporating both samples was to compare responses on the assessments, especially the BADP,
as well as to ensure that the final version of the BADP will be applicable to a broad, generalized
sample. The pain sample also was administered the 20 item version of the Brief Assessment of
Distress and Pain to maximize the probability of selecting the top 4 items for the final version of
the Brief Assessment of Distress and Pain. The final assessment was developed after the
administration of the 20 item version to the undergraduate and pain samples and the scale had
been condensed through confirmatory factor analysis and inspection of items. All participants in
the pain sample were provided only paper and pencil formats of the battery of assessments
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inclusive of the Brief Assessment of Distress and Pain. The presentation order of the assessments
in the battery was: demographic questionnaire, 20-item BADP, FPQ-III, PASS, BDI-II, and a
demographic and health questionnaire. These assessments were selected to be included in the
battery because they assessed the three constructs of interest (i.e., fear, anxiety, and depression).
A shorter battery of assessments was selected due to time constraints as well as in effort to
reduce burden and fatigue on the chronic pain participants. Upon completion of the assessment
battery, participants were thanked, debriefed, and paid $20 for their time and effort.
Results
Expert Judges’ Item Evaluation and Laboratory Item Development
Construct definitions for anxiety, fear, depression, and overall negative affectivity were
examined in the literature as well as discussed within the APPL laboratory. Items were generated
within the laboratory and reduced to 20 items per construct through discussion and item analysis.
All items were subjected to Flesh-Kincaid analyses to determine the grade level of readability of
each item, as shown in Tables 1-2. A list of 16 expert judges who specialize within the fields of
pain and emotion (i.e., physicians and health psychologists) was generated after the item pool
had been condensed. Each judge was contacted via email with a brief description of the project,
instructions on how to evaluate the each item, and the list of the 60 total items; of the 16 judges
who were contacted, 11 (68.8%) responded. In addition, each judge was provided a section
asking for specific feedback on each item. Expert judges rated each item as (a) essential, (b)
useful but not essential, or (c) not necessary. To examine the agreement among each of the
judges of each item, the content validity ratio (CVR) in addition to other factors were assessed
for each item (Lawshe, 1975). The CVR formula that is used for evaluating each item is CVR =
(ne – N/2) / (N/2) where “ne” represents the number of expert judges that rated an item as
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essential and “N” representing the total number of expert judges that rated an item. Values range
from -1 to +1 with more positive values indicating ratings of essential. Further, more positive
scores also indicate a greater degree of content validity. The number of judges included affects
the CVR, such that in the case of 11 judges, only one can note it other than essential and the item
meet criterion. Subsequently, ratings of essential or useful but not essential were considered in
the ne variable in the CVR calculation. Items that did not meet 0.75 criteria outline by Lawshe
(1975) were deleted or revised. Items that possessed the highest CVR with great ratings of
essential or useful but not essential were selected. Based on the judges’ ratings and
recommendations, and the APPL laboratory suggestions, a 20 item version of the BADP was
developed to administer to the undergraduate and pain samples; please refer to Tables 3-6.
Demographics
Undergraduate sample. A total of 503 undergraduate students was collected at West
Virginia University; please refer to Figure 1. The mean age of the undergraduate sample was
19.9 years (SD = 1.8). The majority of the undergraduate sample was single (56.5%). The ethnic
composition of the sample was predominantly Caucasian (91.9%) followed by African-American
(2.9%), Hispanic/Latino (0.7%), American Indian (1.0%), Other (0.5%), and Mixed (3.0%). In
relation to SES, a portion of the undergraduate sample held part-time employment (42.0%) or
were unemployed (37.9%). The rest of the sample held full-time employment (5.0%),
volunteered (2.4%), or listed “other” (12.7%) for employment. Their families’ income was
grouped as follows: $0-20,000 (7.2%), $20-40,000 (13.2%), $40-60,000 (16.1%), $60-80,000
(14.9%), $80-100,000 (12.3%), $100,000 or more (26.7%).
Chronic pain patient sample. A total of 60 chronic pain patients was collected at
Carolina Pain Institute; please refer to Figure 2. The mean age of the pain sample was 54.4 years
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(SD = 11.6) and the sample was predominantly female (62.2%). The ethnic composition of the
sample was predominantly Caucasian (86.7%) followed by African-American (4.4%),
Hispanic/Latino (2.2%), American Indian (2.2%), and Other (4.4%). The majority of the sample
self-perceived themselves as disabled (60.0%). The rest of the sample held full-time employment
(15.6%), part-time employment (4.4%), volunteered (2.2%), were unemployed (6.7%), or listed
“other” (8.9%) for employment. The chronic pain participants’ annual income was grouped as
follows: $0-20,000 (35.6%), $20-40,000 (24.4%), $40-60,000 (13.3%), $60-80,000 (11.1%),
$80-100,000 (6.7%), $100,000 or more (8.9%).
Reliability Analysis and Data Cleaning
Undergraduate sample. To ensure high quality data for the undergraduate sample, seven
reliability items were included in the online survey. Participants were required to select a specific
answer option or enter a specific code on four of the seven seven items. The other three items
were taken from the FPQ-III (i.e., item 10), TSK-11 (i.e., item 3), and the BDI-II (i.e., item 8)
assessments. One item from each of these scales was repeated at the end of the scale within the
online survey.
To determine the reliability of each participant’s responses, duration spent taking the
online assessment battery was examined first. The mean duration was found to be 25.8 minutes
with a standard deviation of 11.9 minutes. The data were examined for trends, and inspected in
terms of 1 and 2 standard deviation cut off scores. It was determined that a cut-off score of
13minutes would be optimal. Specifically, any individual who spent less than 13 minutes taking
the survey was eliminated, and the one outlier of 133 minutes was removed from the data set.
Decline to answer options on specific demographic items were examined next.
Frequencies for demographic items were calculated and reviewed. Participants who responded
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to demographic items with three or less “decline to answer” selections were removed, in addition
to individuals who declined to answer on specific dichotomous pain items (i.e., “yes” or “no” to
the presence of pain). After these items were removed, a total of 448 participants was left in the
sample.
The seven reliability items were examined and divided such that those that required a
specific response were examined together, and those that were duplicated assessment items were
examined together. The three reliability items that required a specific response were coded for
accuracy. Coded items were then summed across reliability items. Initially, any participant who
missed an item on this grouping of reliability items or selected decline to answer or not
applicable answer options was considered for removal which could have left a sample of N =
414. In combination with the previously decided upon criteria for the other set of reliability items
(i.e., assessment reliability items), this criterion was found to be too stringent, which would have
led to a sample of 392. A final decision was made to retain any individual who missed just one of
the four non-repeated assessment reliability items. All individuals who missed more than one of
these reliability items or selected decline to answer or not applicable were removed, leading to a
final useable sample of 442.
There was a total of three duplicated assessment items from the BDI-II (i.e., item 8),
FPQ-III (i.e., item 10), and the TSK-11 (i.e., item 3) which were examined last. Each duplicated
item occurred at the end of the same assessment section. Due to each of the assessments having
different scales in relation to their answer options, different criteria were used to code each
assessment. The BDI-II and the TSK-11 are both constructed as 4 point scales whereas the FPQIII was constructed as a 5 point scale. It was decided that individuals would be allowed to vary
by 1 point on their selected answer options on the BDI-II and the TSK-11 and by 2 points on the
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their selected answer options on the FPQ-III. Any individual who did not meet the decided upon
criteria was excluded which led to a final sample of 416. Out of the 416 individuals left, one
individual declined to answer on multiple items on the Brief Assessment of Distress and Pain
(BADP) and was eliminated leaving a final total sample of 415; please refer to Figure 1.
Chronic pain sample. In relation to the pain sample, seven chronic pain patients missed
at least one item or more on the assessment battery or failed to provide a specific response
option. These seven individuals were removed from the final data set, bringing the total sample
to a total of 53. After further examination, eight chronic pain patients required assistance with
completing the battery of assessments. Because of the possibility that these individuals may have
altered their responses due to the presence of another individual, these eight individuals were
also removed from the final data set. One of these eight individuals also missed at least one item
or failed to provide a specific response option. Two other participants provided highly discrepant
answers and were thus removed from the final data set due to inconsistent responding. After
cleaning the data, the final sample consisted of 45 chronic pain patients; please refer to Figure 2.
Descriptive Statistics and t-Tests
Means and standard deviations for the total and subscale scores of the BADP, FPQ-III,
PASS, and BDI-II were examined in undergraduate sample and the chronic pain sample. Overall,
the pain sample was elevated on most of the measures (i.e., BADP Depression subscale, BADP
Overall Negative Affectivity subscale, BADP total score, BDI-II total score, all subscales of the
FPQ-III, and the Escape Avoidance subscale of the PASS) as compared to the undergraduate
sample; please refer to Table 7.
Independent t-tests were conducted to determine if there were any significant differences
between the subjects who were removed from those that were retained in the undergraduate and
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pain samples for the following variables: age, BADP Overall Negative Affect subscale, and
BADP total score. Participants who were removed (M = 19.9, SD = 1.6) from the undergraduate
sample did not differ significantly on age (t (499) = .05, p = .96) from participants who were kept
(M = 19.9, SD = 1.8). The participants who were removed (M = 6.4, SD = 4.1) also did not differ
from those who were retained (M = 6.1, SD = 4.6) on the BADP Overall Negative Affect
subscale (t (499) = .57, p = .57). The results were similar for the BADP total scale t (499) = .33,
p = .75) for those who were removed (M =26.4, SD = 14.7) as compared to those who were
retained (M = 25.8, SD = 16.3).
Participants who were removed (M = 52.7, SD = 13.9) from the pain sample did not
differ significantly from those retained (M = 54.4, SD = 11.6) on age (t (58) = .47, p = .64).
Those who were removed (M = 9.7, SD = 6.6) also did not differ from those retained (M = 8.4,
SD = 6.6) on the BADP Overall Negative Affect subscale (t (58) = -.66, p = .51). This same
pattern was found for the BADP total scale t (58) = -.33, p = .74) for those who were removed
(M = 34.9, SD = 25.7) as compared to those retained (M = 32.4, SD = 24.5).
Intra and Inter-Scale Correlation Coefficients
Data from all 20 items of the BADP provided by the 415 undergraduate student
participants, the 45 chronic pain participants, and the combined samples were subjected to intraand inter-correlation analyses; please refer to Tables 8-15. Pearson correlation coefficients were
examined within the hypothesized subscales of the BADP as well as across other assessments
scales (i.e., BDI-II, PASS, and the FPQ-III).
Intra-correlations indicated a high degree of relation among all scales and items.
Specifically, moderate to highly association was found among all the subscales of the BADP,
refer to Tables 8-11. In terms of inter-correlation coefficients, the subscales of the BADP were
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found to be related to the majority of the subscales and full scales of the other assessments
included in the battery.
The BADP fear subscale was slightly to moderately related to the BDI-II, the FPQ-III’s
Minor Pain, Severe Pain, Medical/Dental subscales, and the FPQ-III total scale (0.38 < r < 0.74).
The fear subscale of the BADP was found to be moderately to highly associated with the PASS
Fear subscale, the PASS Cognitive Anxiety, Escape Avoidance, Physiological Anxiety
subscales, and the PASS total scale (0.49 < r < 0.82); please refer to Table 12.
The BADP anxiety subscale was slightly to moderately related to the BDI-II, the FPQIII’s Minor Pain, Severe Pain, Medical subscales, and the FPQ-III total scale (0.37 < r < 0.70).
The anxiety subscale of the BADP was found to be moderately to highly associated with the
PASS Fear subscale, the PASS Cognitive Anxiety, Escape Avoidance, Physiological Anxiety
subscales, and the PASS total scale (0.48 < r < 0.82); please refer to Table 13.
The depression subscale was slightly to moderately related to the BDI-II, the FPQ-III’s
Minor Pain, Severe Pain, the Medical subscales, the FPQ-III total scale, the PASS Escape
Avoidance, and the PASS Physiological Anxiety subscales (0.23 < r < 0.73). The depression
subscale of the BADP was found to be moderately to highly associated with the PASS Fear,
Cognitive Anxiety subscales, and the PASS total scale (0.53 < r < 0.85); please refer to Table 14.
The BADP overall negative affect subscale was low to moderately related to the BDI-II,
the FPQ-III’s Minor Pain, Severe Pain, Medical subscales, and the FPQ-III total scale (0.25 < r <
0.74). The overall negative affect subscale of the BADP was found to be moderately to highly
associated with the PASS Fear, Cognitive Anxiety, Escape Avoidance, Physiological Anxiety
subscales, and the PASS total scale (0.59 < r < 0.85); please refer to Table 15.
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Discriminant Validity
As planned, the FQ-Ag was utilized only with the undergraduate sample. Correlations
between the BADP subscales, and the BADP total score, and the FQ-Ag were low (.25 < r < .31)
indicating some degree of discriminant validity; please refer to Table 16.
Principal Components Analysis
Exploratory factor analysis (i.e., Principal Components Analysis or PCA) was conducted
on the 20 item version of the BADP for the undergraduate sample and the combined sample (i.e.,
pain sample and the undergraduate sample). A PCA was not conducted on the pain sample alone
due to the limited power and the number of total participants (N = 45). For all PCA analyses, a
varimax rotation was utilized.
For the undergraduate sample, the Kaiser-Meyer-Olkin measure verified the sampling
adequacy for the analysis, KMO = .97, which is listed as within the “superb” range (Field, 2009).
The combination of the KMO and Bartlett’s test of sphericity indicated that the data were
adequate to conduct a PCA. Bartlett’s test of sphericity χ2 (190) = 6687.45, p < .001, indicated
that correlations between items were sufficiently large for PCA. An initial analysis was
conducted to determine eigenvalues for each component in the data. Three components had
eigenvalues over Kaiser’s criterion of 1 and in combination explained 70.04% of the variance.
The first component accounted for 58.91% of the total variance with an eigenvalue of 11.78 The
second component only accounted for 6.04% of the total variance with an eigenvalue of 1.21.
The third component accounted for only 5.09% of the total variance with an eigenvalue of 1.02.
The scree plot, on the other hand, displayed what appeared to be predominately a one component
scale. The recommended cut-point of .40 was utilized for the examination of the factor loadings
of the BADP items. This component appears to be related to overall negative affectivity in
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relation to the experience of pain. BADP items 1, 3, 4, 5, 11, 12, 14, 16, and 20 did not crossload on the rotated component matrix. On the rotated component matrix, it appeared that items
from the anxiety and fear subscales clustered together, whereas the depression and overall
negative affectivity subscales clustered together. After examination of the rotated component
matrix and the scree plot, an additional PCA was conducted on these items to determine whether
there were two separate components (i.e., one component consisting of fear and anxiety and the
other of depression and overall negative affectivity). After conducting the secondary PCA, only
one component emerged; please refer to Table 17 for the factor loadings of the individual BADP
items.
To further examine the two component structure, a PCA was conducted on BADP items
1, 3, 4, 5, 11, 12, 14, 16, and 20 with a forced three component structure. The Kaiser-MeyerOlkin measure verified the sampling adequacy for the analysis, KMO = .97, which is listed as
within the “superb” range (Field, 2009). The combination of the KMO and Bartlett’s test of
sphericity indicated that the data were adequate to conduct a PCA. Bartlett’s test of sphericity χ2
(190) = 6687.45, p < .001, indicated that correlations between items were sufficiently large for
PCA. An initial analysis was conducted to determine eigenvalues for each component in the data.
The first component had an eigenvalue over Kaiser’s criterion of 1 and explained 58.91% of the
variance. The second component explained only 6.04% of the variance. The third component
explained only 5.09% of the variance. The scree plot confirmed a predominately one factor scale.
In examining the rotated component matrix, anxiety and fear items still clustered together
whereas depression and overall negative affectivity clustered together. Given the large sample
size, the scree plot, and Kaiser’s criterion, one component was retained for the undergraduate
sample.
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For the combined sample, the Kaiser-Meyer-Olkin measure verified the sampling
adequacy for the analysis, KMO = .97, which is listed as within the “superb” range (Field, 2009).
The combination of the KMO and Bartlett’s test of sphericity indicated that the data were
adequate to conduct a PCA. Bartlett’s test of sphericity χ2 (190) = 8070.92, p < .001, indicated
that correlations between items were sufficiently large for PCA. An initial analysis was
conducted to determine eigenvalues for each component in the data. Two components had
eigenvalues over Kaiser’s criterion of 1 and in combination explained 67.76% of the variance.
The first component accounted for 61.90% of the total variance with an eigenvalue of 12.38. The
second component only accounted for 5.86% of the total variance with an eigenvalue of 1.17.
The scree plot, on the other hand, displayed what appeared to be predominately a one component
scale. The recommended cut-point of .40 was utilized for the examination of the factor loadings
of the BADP items. This component appears to be related to overall negative affectivity in
relation to the experience of pain. BADP items 1, 4, 6, 7, 11, 12, 13, 14, 16, and 17 did not crossload on the rotated component matrix. An additional PCA was conducted on these items to
determine whether there were in fact two separate components (i.e., one component consisting of
fear and anxiety and the other of depression and overall negative affectivity) in the scale. After
conducting the secondary PCA, only one component emerged; please refer to Table 18 for the
factor loadings of the individual BADP items.
To further examine the two component structure, a PCA was conducted on BADP items
1, 4, 6, 7, 11, 12, 13, 14, 16, and 17 with a forced two factor structure. The Kaiser-Meyer-Olkin
measure verified the sampling adequacy for the analysis, KMO = .93, which is listed as within
the “superb” range (Field, 2009). The combination of the KMO and Bartlett’s test of sphericity
indicated that the data was adequate to conduct a PCA. Bartlett’s test of sphericity χ2 (45) =
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2955.11, p < .001, indicated that correlations between items were sufficiently large for PCA. An
initial analysis was conducted to determine eigenvalues for each component in the data. One
component had an eigenvalue over Kaiser’s criterion of 1 and explained 60.73% of the variance.
The next component almost reached Kaiser’s criterion of 1 (.97) and explained only 9.74% of the
variance. The scree plot appeared to confirm a one factor scale. In examining the rotated
component matrix, anxiety and fear items again clustered together whereas depression and
overall negative affect clustered together. Given the large sample size, the scree plot, and
Kaiser’s criterion, one component was retained for the combined sample.
Internal Consistency
The Fear, Anxiety, Depression, and Overall Negative Affectivity subscales for the
undergraduate sample were found to have high reliability with a Cronbach’s .88 < α < .89. The
full-scale BADP had high reliability as well, Cronbach’s α = .96; please refer to Table 19.
The subscales of the BADP (i.e., Fear, Anxiety, Depression, and Overall Negative
Affectivity) for the combined sample also had high reliability with Cronbach’s α of .90 < α <
.91. The full-scale BADP had high reliability as well, Cronbach’s α = .97, please refer to Table
20.
Item Selection
Final item selection of BADP involved examination and comparison of intra- and intercorrelation coefficients as well as PCA results. Specifically, items that did not cross-load onto
multiple factors were examined in depth; please refer to Tables 16 and 17 for the factor loadings
of the selected items. The CVR values based on the expert judges’ ratings also were examined
for each of the items. Based on the correlation coefficients, the CVR values, and the PCA results,
the top four items from each subscale were selected. These items then were reviewed for ease of

24
BRIEF ASSESSMENT OF DISTRESS AND PAIN
readability and the final items (i.e., one per subscale) of the BADP were selected; please refer to
Table 21.
Discussion
These data suggest the BADP is a good measure of negative affectivity related to pain.
Items from the BADP were subjected to a stringent developmental process. Items were
developed by a research group, evaluated by experts within the field of emotion and pain, tested
in an undergraduate sample, and then applied to a heterogeneous sample of chronic pain patients.
Alpha coefficients for the BADP and its subscales indicated strong internal consistency.
Intra-scale correlation coefficients revealed that subscales of the BADP were related. The high
degree of relation among the subscales of the BADP was expected given the high degree of
comorbidity of the constructs assessed by the BADP. There was still, however, some degree of
distinction among the subscales of the BADP indicating that the BADP, was able to distinguish
among the constructs to some extent.
Inter-scale correlation coefficients for the BADP indicated moderate to high degrees of
convergent validity with the BDI-II, FPQ-III, and the PASS, all of which reflect similar
constructs. In relation to divergent validity, correlation coefficients for the BADP indicated only
a low association with the FQ-Ag. It was expected that the depression subscale and the overall
negative affect subscale would be highly correlated given the degree of overlap of these
particular constructs.
Of note, inter-correlation coefficients for the undergraduate sample were low as
compared to the inter-correlation coefficients for the pain sample and the combined sample (i.e.,
pain and undergraduate sample) on all of the different subscales and scales in the battery of
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assessments. It is likely that this finding may reflect the undergraduate sample’s limited
experience with pain.
PCA results suggested a single component structure for the BADP which assesses overall
negative affectivity in relation to the experience of pain. The PCA findings suggest that the
BADP assesses a general emotional response to pain. The general nature of the responses may be
related to different factors, depending on the sample. It is possible that the undergraduate sample
has had limited experience with pain, which led to their responses being similar across scales.
Due to the pain sample’s consistent and long-term experience with pain, they may have
responded in such a way in which any negative emotions associated with pain are lumped
together.
Despite the PCA indicating a single factor structure of the BADP, the goal in designing
the BADP was to create a short assessment which could be administered in health-care settings.
Even though the original plan was to create items which could distinguish among the constructs
of fear, anxiety, depression, and overall negative affectivity, one overall item still could serve the
desired purpose of early identification of individuals. Further, the use of a one item scale to
identify clinically significant conditions would increase the ease of early assessment in
healthcare settings and reduce the burden of scoring.
A limitation of the present study includes the small sample of chronic pain patients (N =
45). The pain sample’s data could not be investigated through a PCA in isolation, and had to be
combined with undergraduate sample to provide a sufficient sample size for analysis.
Specifically, variability in response patterns would have been more detectable if the two samples
would have been kept separate. A larger heterogeneous chronic pain sample (i.e., > 100) would
have been more ideal for PCA to be conducted on the pain sample in isolation. Another
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limitation includes the use of different methods of assessment (i.e., SONA vs. paper and pencil
format) across the two sample types. It would have been more ideal to choose one methodology
across samples for consistency. The shorter battery presented to the pain sample was another
limitation. The reduced assessment battery for the pain sample was beneficial in reducing
burden, but limited the degree of comparison with the other assessments that were only included
in the undergraduate assessment battery (i.e., ASI-3, TSK-11, FABQ, and the FQ-Ag). The
ordering of the assessment batteries was different between samples. It would have been ideal to
have administered the same assessments in the same sequence to both samples.
A strength of the present study was the multiple stages of analyses that were conducted to
develop and analyze the BADP. Specifically, all items were developed based on construct
definitions from the literature and were evaluated by members of a research group with
experience in the area. The use of expert judges to evaluate each item and provide feedback
increased the content validity of the items of the BADP. Another strength of the current study
was the inclusion of the heterogeneous chronic pain sample, which allowed for analysis of the
psychometric properties of the BADP with patients who are comparable to those whom the
BADP was intended to assess.
There is a need for brief assessments in healthcare settings. Short assessments allow for
ease of administration, scoring, and interpretation of clinical conditions and issues. Brief
assessments can assist in early identification of affected individuals allowing for more
comprehensive assessments and treatments. Although still early in the developmental phase, the
BADP has displayed utility in identifying relations among negative emotional states and pain.
The constructs assessed by the BADP (i.e., fear, anxiety, depression, and overall negative
affectivity) are multi-dimensional in nature and are highly comorbid, leading to difficulty in
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designing an assessment that is capable of successfully making distinctions among the
constructs. Nevertheless, the BADP, including its single item assessment, has great promise as a
screening measure. Through further development and analysis, the BADP could address the need
in the literature for a brief measure that assesses fear, anxiety, depression, and overall negative
affectivity in relation to the experience of pain in health-based settings.
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Table 1.
Flesch-Kincaid Readability Tests
BADP Item
Number

1. Thinking
ahead about
something
painful, I get
really worried

2. All in all, I get
emotionally
upset about
pain.

3. I feel
hopeless
about
situations in
which I am
not able to
control or
reduce pain.

Grade
Level

10.2

7.5

8.3

Readability
Ease

37.9

56.7

63.6

4. I fear
situations
that are
physically
painful.

5. Just before I
experience
something
painful, I get
really uptight.

6. The
fact that I
might feel
pain
causes
me to
feel sad.

7. Pain
causes me
to have
strong
negative
feelings

8. It is
difficult to
not be
afraid of
pain.

9. I worry
about
feeling
pain

10. I feel sad
about the
thought of
feeling pain.

9

9.5

1.8

5.2

3.6

5.2

2.3

42.6

44.4

100

71.8

84.9

66.4

94.3

Note. The 20-item version of the BADP administered to both samples. The readability ease test is based on the mathematical formula
that assesses average sentence length and the average number of syllables per word. Easier to read sentences have higher readability
ease scores. Scores of 90-100 are at a 5th grade level. Scores of 60-70 are at an 8-9th grade level. Scores of 0-30 are at a college
graduate level.
*MyByline Media. (2013). The Flesch Reading Ease Readability Formula. Readability Formulas: Free readability tools to check Reading Levels, Reading Assessment, and
Reading Grade Levels. Retrieved from: http://www.readabilityformulas.com/flesch-reading-ease-readability-formula.php.
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Table 2.
Flesch-Kincaid Readability Tests continued
BADP Item
Number

11. The fact
that I could
feel pain in
the
future
worries me a
lot.

12. I am
emotionally
upset when I
experience
pain

13. I am
scared of
feeling pain.

14. When I
am in pain, I
feel
hopeless.

15. I feel really
nervous when
I think about
being in pain.

16. I feel
a sudden
sense of
fear I am
about to
feel pain

17. Being
in pain
makes me
feel sad.

18. I am
really
troubled
when I
think about
my pain.

19. It is
hard to not
be worried
about my
pain.

20. All in all,
pain causes me
to feel
emotionally
distressed.

Grade
Level

3.3

9.6

0.5

2.2

3.7

3

0

3.6

2.4

7.1

Readability
Ease

95.9

40

100

92.9

87.9

96

100

86.7

95.1

61.3

Note. The 20-item version of the BADP administered to both samples. The readability ease test is based on the mathematical formula
that assesses average sentence length and the average number of syllables per word. Easier to read sentences have higher readabilit y
ease scores. Scores of 90-100 are at a 5th grade level. Scores of 60-70 are at an 8-9th grade level. Scores of 0-30 are at a college
graduate level.
*MyByline Media. (2013). The Flesch Reading Ease Readability Formula. Readability Formulas: Free readability tools to check Reading Levels, Reading Assessment, and
Reading Grade Levels. Retrieved from: http://www.readabilityformulas.com/flesch-reading-ease-readability-formula.php.
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Table 3.
CVRs for the Fear Subscale
FEAR

CVR-Essential and
Maybe Essential

1. I am scared of feeling pain.

.82

2. I avoid painful situations at all costs because I feel
afraid.

.45

3. Feeling pain causes me to feel frightened.
4. I feel scared just before I have pain.
5. I am very afraid of situations in which I am not able to
control pain.
6. When I think about being in pain, I feel scared.
7. Knowing that I am going to have pain is very scary to
me.
8. I fear parts of life that are physically painful.
9. When I am in pain, I feel scared.
10. It is difficult to not be afraid of pain.
11. When I am about to experience pain, I become fearful.

.27
.09
.40
.27
.27
-.27
.64
-.09
.09

12. Just before I experience something painful, I get really
uptight.

-.27

13. When I am just about to experience pain, fear
overwhelms me.

.09

14. When pain is about to begin, I feel afraid.
15. Fear comes over me when I know I am about to feel
pain.

-.09
-.27
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Table 4.
CVR for the Anxiety Subscale
ANXIETY

CVR-Essential and Maybe
Essential

1. I worry about feeling pain.

1.0

2. I worry about situations that probably will
involve pain.

1.0

3. I avoid painful situations at all costs because
I am anxious.

.27

4. I worry about painful situations.

.64

5. I am nervous about pain.

.64

6. The fact that I could feel pain in the future
worries me a lot.

.09

7. Knowing that I will likely experience pain
makes me feel anxious.

.64

8. I feel anxious when I think about being in
pain.

1.0

9. It is hard to not be worried about pain.

.09

10. When I think about being in pain, I feel
anxious.

.82

11. I feel nervous when I think about
experiencing something painful.

.64

12. I worry a lot about pain.

.82

13. Thinking ahead about something painful, I
get really worried.

.27

14. My nerves get really bad when I think
about being in pain.

-.60

15. When I think about pain, I feel anxious.

.60
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Table 5.
CVR for the Depression Subscale
DEPRESSION

CVR-Essential and
Maybe Essential

1. I feel down about experiencing pain.

.27

2. The thought of experiencing pain causes me to feel
depressed.

.64

3. Thinking about pain causes me to feel depressed.
4. Experiencing pain causes me to feel hopeless.
5. I feel depressed about pain.
6. I feel hopeless about situations in which I am not able to
control or reduce pain.
7. The fact that I might feel pain causes me to feel sad.
8. Knowing that I will likely feel pain makes me feel
helpless.
9. I feel sad about the thought of feeling pain.
10. When I am in pain, I feel hopeless.
11. When I think about being in pain, I feel sad.
12. I get really sad when I know I am going to experience
something painful.
13. Sadness comes over me when I am in pain.
14. Being in pain makes me feel sad.
15. When I am about to experience pain, I become
depressed.

.64
.45
.64
.27
.09
.45
.09
.64
.64
.45
.64
.82
.27
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Table 6.
CVR for the Overall Negative Affectivity Subscale
OVERALL NEGATIVE AFFECT

CVR-Essential and Maybe
Essential

1. All things considered, I have lots of concerns
about pain.

.27

2. I am troubled by situations in which I probably
will feel pain.

.64

3. Thinking about pain causes me to feel upset.
4. All in all, I get emotionally upset about pain.
5. Pain causes me to have strong negative feelings.
6. The fact that I could feel pain bothers me a lot.

.64
.27
.45
.64

7. Knowing that I will likely feel pain makes me
feel awful.

.45

8. I am bothered by the thought of going through
pain.

.82

9. Painful situations are emotionally distressing to
me.

.45

10. All in all, pain causes me to feel emotionally
distraught.

.45

11. I am really troubled when I think about pain.

.45

12. When I think about being in pain, I feel
distressed.

.64

13. All things considered, I have lots of negative
emotions about feeling pain.

.45

14. I am emotionally upset when I experience pain.
15. All things considered, I have lots of negative
feelings about experiencing pain.

1.0
.45
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Table 7.
Descriptive Statistics and Comparison of Scores across Samples on Assessment Scales
Undergraduate
Sample

Pain Sample
Mean

SD

Mean

SD

t

p

8.22

6.50

.49

.63

BADP Fear
Subscale

7.55

4.53

BADP
BADP Fear
Subscale

BADP Anxiety
Subscale

6.78

4.38

BADP Anxiety
Subscale

7.87

6.06

1.52

.13

7.91

6.11

4.14

< .001

BADP Depression
Subscale

5.36

4.12

BADP Depression
Subscale

BADP ONA
Subscale
BADP Total

6.09
25.79

4.57
16.27

BADP ONA
Subscale
BADP Total

8.44
32.44

6.56
24.46

3.12
2.46

< .05
< .05

9.59

BDI-II
BDI-II Total

17.73

11.23

4.96

< .001

20.13

11.07

9.90

< .001

29.33

12.37

3.52

< .001

23.91
73.38

11.40
32.65

5.33
6.99

< .001
< .001

BDI-II Total

10.13

FPQ-III
FPQ-III Minor Pain
Subscale
FPQ-III Severe
Pain Subscale
FPQ-III Medical
Pain Subscale
FPQ-III Total

10.23

5.65

24.67

7.69

16.92
51.73

7.97
17.53

FPQ-III Minor Pain
Subscale
FPQ-III Severe
Pain Subscale
FPQ-III Medical
Pain Subscale
FPQ-III Total
PASS

PASS Fear
Subscale

20.45

6.51

PASS Fear
Subscale

21.60

10.12

-.30

.76

PASS Cognitive
Anxiety Subscale

22.79

6.91

PASS Cognitive
Anxiety Subscale

20.11

10.64

1.06

.29

6.37

PASS
Escape/Avoidance
Subscale

24.02

11.13

3.10

< .05

8.70
25.27

PASS
Physiological
Anxiety Subscale
PASS Total

26.64
91.24

9.68
40.55

.44
1.14

.66
.25

PASS
Escape/Avoidance
Subscale
PASS
Physiological
Anxiety Subscale
PASS Total

23.36

19.84
86.46

*Note. Student’s t-tests reported.
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Table 8.
Intra-scale Correlation Coefficients for Fear items
Fear
Item #

Fear
SubscaleUG

Fear
SubscalePain

Fear
SubscaleBoth

Anxiety
SubscaleUG

Anxiety
SubscalePain

Anxiety
SubscaleBoth

Depression
SubscaleUG

Depression
SubscalePain

Depression
SubscaleBoth

ONA
SubscaleUG

ONA
SubscalePain

ONA
SubscaleBoth

TotalUG

TotalPain

Total
ScaleBoth

4

.81

.91

.82

.70

.79

.71

.57

.79

.60

.62

.74

.63

.73

.83

.74

5

.81

.92

.81

.73

.81

.74

.72

.80

.75

.65

.76

.68

.79

.85

.80

8

.85

.92

.86

.75

.88

.77

.63

.87

.65

.66

.85

.68

.78

.90

.79

13

.87

.92

.87

.75

.91

.76

.64

.89

.65

.66

.82

.67

.79

.91

.79

16

.83

.93

.84

.76

.87

.77

.61

.85

.62

.68

.81

.68

.78

.89

.78

Note. All correlations were significant at p < .01; UG = Undergraduate Sample; Pain = Pain Sample; Both = Combined Sample; ONA
= Overall Negative Affect subscale
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Table 9.
Intra-scale Correlation Coefficients for Anxiety Items
Anxiety
Item #

Fear
SubscaleUG

Fear
SubscalePain

Fear
SubscaleBoth

Anxiety
SubscaleUG

Anxiety
SubscalePain

Anxiety
SubscaleBoth

Depression
SubscaleUG

Depression
SubscalePain

Depression
SubscaleBoth

ONA
SubscaleUG

ONA
SubscalePain

ONA
SubscaleBoth

TotalUG

TotalPain

Total
ScaleBoth

1

.71

.82

.72

.80

.87

.81

.57

.83

.60

.61

.82

.64

.73

.86

.74

9

.77

.92

.80

.82

.93

.84

.69

.92

.73

.68

.88

.71

.80

.94

.83

11

.63

.78

.65

.76

.91

.78

.52

.83

.56

.61

.81

.63

.68

.86

.70

15

.79

.88

.80

.88

.96

.89

.65

.88

.68

.68

.88

.71

.81

.93

.83

19

.74

.87

.75

.83

.95

.85

.66

.92

.71

.70

.93

.74

.79

.94

.82

Note. All correlations were significant at p < .01; UG = Undergraduate Sample; Pain = Pain Sample; Both = Combined Sample; ONA
= Overall Negative Affect subscale
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Table 10.
Intra-scale Correlation Coefficients for Depression items
Depression
Item #

Fear
SubscaleUG

Fear
SubscalePain

Fear
SubscaleBoth

Anxiety
SubscaleUG

Anxiety
SubscalePain

Anxiety
SubscaleBoth

Depression
SubscaleUG

Depression
SubscalePain

Depression
SubscaleBoth

ONA
SubscaleUG

ONA
SubscalePain

ONA
SubscaleBoth

TotalUG

TotalPain

Total
ScaleBoth

3

.60

.81

.63

.55

.86

.60

.75

.92

.78

.62

.87

.67

.68

.85

.72

6

.67

.90

.70

.66

.88

.70

.84

.91

.85

.69

.85

.72

.77

.91

.80

10

.69

.88

.71

.70

.90

.73

.86

.94

.88

.71

.87

.75

.80

.93

.82

14

.62

.81

.65

.62

.90

.66

.84

.93

.86

.77

.90

.79

.77

.91

.79

17

.56

.82

.59

.55

.85

.60

.81

.93

.84

.69

.88

.73

.70

.90

.74

Note. All correlations were significant at p < .01; UG = Undergraduate Sample; Pain = Pain Sample; Both = Combined Sample; ONA
= Overall Negative Affect subscale
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Table 11.
Intra-scale Correlation Coefficients for Overall Negative Affect items
Overall
Negative
Affect
Item #

Fear
SubscaleUG

Fear
SubscalePain

Fear
SubscaleBoth

Anxiety
SubscaleUG

Anxiety
SubscalePain

Anxiety
SubscaleBoth

Depression
SubscaleUG

Depression
SubscalePain

Depression
SubscaleBoth

ONA
SubscaleUG

ONA
SubscalePain

ONA
SubscaleBoth

TotalUG

TotalPain

Total
ScaleBoth

2

.66

.82

.68

.67

.87

.70

.72

.88

.75

.84

.93

.86

.78

.90

.80

7

.64

.73

.65

.63

.80

.66

.70

.81

.72

.80

.89

.82

.75

.83

.77

12

.61

.83

.65

.63

.87

.67

.69

.87

.72

.86

.92

.87

.76

.90

.78

18

.72

.80

.73

.75

.90

.78

.74

.89

.77

.82

.94

.84

.82

.91

.84

20

.68

.83

.70

.71

.89

.73

.74

.92

.77

.90

.93

.90

.82

.92

.83

Note. All correlations were significant at p < .01; UG = Undergraduate Sample; Pain = Pain Sample; Both = Combined Sample; ONA
= Overall Negative Affect subscale
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Table 12.
Inter-Scale Correlation Coefficients for Fear Subscale

Fear Items
4
5
8
13
16
Fear
Subscale

BDI
TotalUG
.12
.20
.19
.20
.24

BDI
TotalPain
.53
.51
.52
.59
.58

BDI
TotalBoth
.17
.28
.24
.23
.26

FPQ
TotalUG
.45
.38
.40
.46
.44

FPQ
TotalPain
.62
.61
.67
.74
.71

FPQ
TotalBoth
.45
.46
.43
.46
.44

PASS
TotalUG
.57
.49
.56
.55
.60

PASS
TotalPain
.72
.77
.72
.78
.79

PASS
TotalBoth
.59
.54
.58
.57
.62

.23

.59

.28

.51

.73

.53

.66

.82

.69

Note. All correlations were significant at p < .01; UG = Undergraduate Sample; Pain = Pain Sample; Both = Combined Sample
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Table 13.
Inter-Scale Correlation Coefficients for Anxiety Subscale

Anxiety
Items
1
9
11
15
19
Anxiety
Subscale

BDI
TotalUG
.18
.22
.18
.18
.25

BDI
TotalPain
.65
.59
.61
.60
.66

BDI
TotalBoth
.23
.28
.23
.25
.33

FPQ
TotalUG
.40
.38
.40
.45
.37

FPQ
TotalPain
.59
.70
.66
.63
.62

FPQ
TotalBoth
.41
.44
.43
.48
.44

PASS
TotalUG
.53
.58
.48
.57
.57

PASS
TotalPain
.73
.79
.75
.75
.77

PASS
TotalBoth
.56
.61
.52
.60
.60

.25

.67

.32

.49

.69

.52

.67

.82

.69

Note. All correlations were significant at p < .01; UG = Undergraduate Sample; Pain = Pain Sample; Both = Combined Sample
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Table 14.
Inter-Scale Correlation Coefficients for Depression Subscale

Depression
Subscale
Items
3
6
10
14
17

BDI
TotalUG
.32
.27
.23
.34
.25

BDI
TotalPain
.62
.57
.57
.68
.63

BDI
TotalBoth
.37
.34
.32
.40
.34

FPQ
TotalUG
.39
.31
.38
.32
.32

FPQ
TotalPain
.53
.67
.67
.67
.64

FPQ
TotalBoth
.42
.42
.48
.40
.43

PASS
TotalUG
.60
.53
.55
.62
.50

PASS
TotalPain
.77
.78
.79
.80
.80

PASS
TotalBoth
.63
.58
.58
.65
.55

Depression
Subscale

.35

.66

.42

.42

.69

.51

.68

.85

.71

Note. All correlations were significant at p < .01; UG = Undergraduate Sample; Pain = Pain Sample; Both = Combined Sample

55
BRIEF ASSESSMENT OF DISTRESS AND PAIN
Table 15.
Inter-Scale Correlation Coefficients for Overall Negative Affect Subscale

ONA Items
2
7
12
18
20
ONA
Subscale

BDI
TotalUG
.31
.29
.26
.25
.29

BDI
TotalPain
.69
.69
.69
.69
.66

.33

.74

BDI
Total-B
.38
.36
.33
.34
.36

FPQ
TotalUG
.38
.30
.35
.35
.36

FPQ
TotalPain
.60
.46
.63
.52
.62

.41

.41

.61

FPQ
Total-B
.43
.36
.41
.40
.42

PASS
TotalUG
.64
.59
.61
.59
.61

PASS
TotalPain
.82
.69
.77
.77
.85

PASS
Total-B
.66
.61
.63
.62
.64

.47

.71

.84

.74

Note. All correlations were significant at p < .01; ONA = Overall Negative Affect; UG = Undergraduate Sample; Pain = Pain Sample;
B = Combined Sample

56
BRIEF ASSESSMENT OF DISTRESS AND PAIN
Table 16.
Discriminant Validity Correlation Coefficients
BADP

FQ-Ag

Fear
Subscale

.25

Anxiety
Subscale

.26

Depression
Subscale

.31

Overall
Negative
Affect
Subscale

.26

Total

.29

Note. All correlations were significant at p < .01.
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Table 17.
Factor Loadings from the Principal Components Analysis – Undergraduate Sample.
BADP Item
#
1

Component
1
-

Component
2
.71

Component
3
-

2

-

.44

.68

3

-

-

.58

4

-

.69

-

5

.75

-

-

6

.74

-

.45

7

.44

-

.56

8

.58

.57

-

9

.68

.46

-

10

.71

-

.48

11

-

.71

-

12

-

-

.79

13

.51

.61

-

14

-

-

.73

15

.57

.63

-

16

-

.73

-

17

.49

-

.67

18

.55

-

-

19

.58

.48

-

20

-

-

.69
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Table 18.
Factor Loadings from the Principal Components Analysis – Combined Sample.
BADP Item
#
1

Component
1
.74

Component
2
-

2

.80

-

3

.71

-

4

.74

-

5

.80

-

6

.80

-

7

.77

-

8

.79

-

9

.83

-

10

.83

-

11

.70

-

12

.78

-

13

.79

-

14

.79

-

15

.83

-

16

.78

-

17

.74

-.42

18

.84

-

19

.82

-

20

.83

-
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Table 19.
Reliability Analysis of the BADP - Undergraduate Sample.
BADP
Alpha
Fear
subscale

.89

Anxiety
subscale

.88

Depression
subscale

.89

Overall
Negative
Affectivity
subscale

.90

Total scale

.96

Note. All alpha values were significant at p < .001.
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Table 20.
Reliability Analysis of the BADP - Combined Sample
BADP
Alpha
Fear
subscale

.90

Anxiety
subscale

.90

Depression
subscale

.90

Overall
Negative
Affectivity
subscale

.91

Total scale

.97

Note. All alpha values were significant at p < .001.
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Table 21.
Final 4-Item Version of the BADP and the Content Validity Ratio of the Selected Items.
BADP

CVR
Value

Fear
Sub-Scale

Anxiety
Sub-Scale

Depression
Sub-Scale

ONA
Sub-Scale

13. I am
scared of
feeling pain.

11. The fact that I
could feel pain in
the
future worries me
a lot.

17. Being in pain
makes me feel sad.

7. Pain causes
me to have
strong negative
feelings

.82

.09

.82

.45

Note. ONA = Overall Negative Affect
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Total Sample (N = 503)

Removed based on 1
SD of Mean Time and
Outlier (N=489)

Removed Decline on
Specfic Demographic
Items (N=448)

Removed Decline, N/A,
or miss more than 1
item on pt 1 reliability
items (N=442)

Removed decline and
miss on assessment
reliability items
(N=416)

Removed All Decline on
BADP Only (N=415)

Figure 1. The undergraduate sample participant decision tree for data cleaning and removal.
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Total Sample (N = 60)

Removed participants who
missed items or failed to
provide a specific response
option (N = 53)

Removed participants who
required assistance with
assessment battery (N = 47)

Removed participants who
answered assessments
inconsistently (duplicate
PASS) (N=45)
Figure 2. Chronic pain participant decision tree for data cleaning and removal.
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Appendix A
Literature Review
Pain
Chronic pain is a common and costly problem around the world including in the U.S.A.
(Gallagher, 1999; Ohayon & Schatzberg, 2003; Turk, 2006). Chronic pain can result in disability
and functional impairment (Gallagher, 1999; Ohayon & Schatzberg, 2003; Turk, 2006).
Additionally, pain is one of the most common treated by primary care providers (Chronic Pain,
2008). Researchers have found that the greater the intensity of the experience of pain, the greater
the likelihood of social and functional disability (Karoly, Okun, Ruehlman, & Pugliese, 2008).
Costs associated with pain treatment were estimated to exceed $200 billion, or 1.37% of the
gross domestic product of the U.S.A. in 2010, which was roughly $14, 582, 400, (American
Academy of Orthopaedic Surgeons, 2010; World Bank, 2011). Other sources estimated that
roughly $560 billion to $635 billion was spent in treatment related to various pain conditions in
the USA in 2010 (American Academy of Pain Medicine, n.d.).
Pain is described as an emotional and sensory experience that is unpleasant, involves
tissue damage or the potential for it, or is characterized in terms of this damage (International
Association for the Study of Pain, 2011). Pain also has been defined as a sensation that is
composed of behavioral, biological, cognitive, affective, and social elements (Bailey, Carleton,
Vlaeyen, & Asmundson, 2010; De Peuter, de Jong, Crombez, & Vlaeyen, 2009; Mok & Lee,
2008). There are several distinctions in the types of pain experienced which are not mutually
exclusive, some of which are: acute, chronic, nociceptive, and neuropathic pain.
Acute pain. Short term pain or acute pain has been defined as physiological response
that is composed of a complex interaction of sensory, psychosocial, and physiological
components which usually has an identifiable cause (Keene et al., 2011). It also has been

65
BRIEF ASSESSMENT OF DISTRESS AND PAIN
described as having a sudden onset and having a short duration (Carr & Goudas, 1999). Acute
pain functions as a warning or alarm of illness or potential threat to the body, leading to
increased attention to the source of pain as well as attempts to protect the injured area and
avoidance of future experiences of potential pain (Lumley et al., 2011). Further, acute pain can
be quite variable, lasting anywhere from a few moments up to several weeks or even months,
typically with fluctuating intensity (Carr & Goudas, 1999; Zeller, Burke, & Glass, 2008). Acute
pain does not last longer than three to six months; if it persists beyond this point, it is labeled
chronic pain (Bruehl & Chung, 2004). In fact, acute pain is a significant risk factor for the
development of chronic pain (Sinatra, 2010). The specific factors that may predispose a person
suffering from acute pain to develop chronic pain are not well understood, but there appears to
be a significant number of individuals who suffer acute pain associated with surgical procedures
and illness who then later develop chronic pain (Sinatra, 2010). Further, the intensity of acute
pain experienced after surgical procedures has been found to be a significant risk factor for the
development of chronic pain (Sinatra, 2010).
Pain catastrophizing “is characterized by the tendency to magnify the threat value of pain
[stimuli] and to feel helpless in the context of pain, and by a realtively inability to inhibit painrelated thoughts in anticipation of, during, of following a painful encounter” (Quartana,
Campbell, Edwards, 2009, p. 2). In relation the experience of acute pain, pain catastrophization
is thought to lead to persistent pain conditions, greater sensation of pain, and maladjustment
(Lumley et al., 2011). Further, high pain catastrophizers who suppress emotions associated with
a painful experience are more likely to report pain as more intense and also have delayed
recovery from acute pain conditions (Gilliam et al., 2009). Attempts to suppress acute pain have
been found to be related to acute pain intensity (Uysal & Lu, 2011). Specifically, the more one
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attempts to suppress, the greater the intensity of acute pain (Uysal & Lu, 2011). Some evidence
has indicated that acute and chronic pain may exist along some continuum instead of previous
findings indicating that these constructs were separate (Keene et al., 2011). Effectively managing
acute pain can lead to more positive outcomes and prevent the progression from acute pain to
chronic pain (Sinatra, 2010). Examples of acute pain include labor pain, dental and medical
procedures, headaches, broken bones, surgery, and burns or cuts (Bruehl & Chung, 2004). Acute
pain has been found to lead to decreased functionality, impaired social functioning, and
decreased reports of quality of life (Sinatra, 2010). Further, the effects of acute pain have been
found to impair sleep, mood, sexual functioning, and performance of physical activities (Sinatra,
2010). In relation to medical settings and post-surgical procedures, acute pain has been found to
be highly correlated with longer hospital stays and more missed physical therapy sessions
(Sinatra, 2010). Acute pain often is prevented or treated through pharmacotherapy, although selfmanagement and behavioral means frequently are utilized (Lumley et al., 2011).
Chronic pain. In contrast to acute pain, chronic pain persists longer than 3-6 months
(Harris, 2011; Robinson, 2007). Examples of types of chronic pain are fibromyalgia, arthritis,
neurogenic pain, lower back pain, cancer pain, and headache pain (Hadjistavropoulos &
Williams, 2004; Harris, 2011). There are certain presentations of chronic pain that are
representative of injury, tissue damage, disease, or trauma, such as joint degeneration, cancer
pain, neuropathic pain, and inflammatory diseases (Lumley et al., 2011). Some individuals,
however, may suffer from chronic pain in the absence of any past physical injury (Beesdo,
Jacobi, Hoyer, Low, Hofler, & Wittchen, 2010). Chronic pain can be the result of a dysfunction
in the neurological alarm system that is characteristic of the response to acute pain and leads to
maladaptive behaviors such as avoidance behaviors (Lumley et al., 2011). The transition from
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acute to chronic pain may be best conceptualized through Gatchel’s three stage transitional
model of pain (Gatchel & Dersch, 2002). In this model, the first stage is associated with the
emotional consequences of experiencing pain, which is inclusive of anxiety and fear (Gatchel &
Dersch, 2002). If the pain persists two to four months, the individual passes into stage two,
which leads to the development and maintenance of maladaptive behavior problems such as
depression, anger, learned helplessness, and somatization (Gatchel & Dersch, 2002). Finally, the
individual may move into stage three, which involves the acceptance of a “sick role” thus
abstaining from usual activities (Gatchel & Dersch, 2002). Chronic pain has been associated with
serious disability and can cause negative physical effects such as limited mobility, decreased
energy, appetite fluctuations, and tense muscles (pain, chronic, 2009; Keene et al., 2011). Certain
factors such as numerous surgical procedures, young age, poorly treated pain, and the presence
of damage to the nervous system all have been found to be factors that are associated with
chronic pain in trauma patients (Keene et al., 2011). Chronic pain patients may make more
frequent visits to medical professionals, have high absenteeism from work and other activities,
and undergo extensive evaluation procedures for treatment (Asmundson & Katz, 2009). Chronic
pain also has been found to be a significant risk factor for suicide ideation and suicide attempts
(Fishbain, Bruns, Disorbio, & Lewis, 2009a). Emotional and psychological effects of chronic
pain include depression, fear, anger, anxiety, anxiety sensitivity, and cognitive catastrophizing
(Carleton, Abrams, Kachur, & Asmundson, 2009; Robinson, 2007).
Nociceptive pain. The acute or short-term period following injury is most representative
of nociception (Chronic Pain, 2008). Nociceptive pain is a function of the activation of
nociceptors, which are nerves that respond to physical damage or potential damage to the body
(Chapman, Nakamura & Flores, 1999; Gatchel, R. J., 1999). When physical or potential damage
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triggers nociceptive nerves, the neural signal is transmitted from the peripheral nervous system to
the central nervous system, specifically to the brain (Turk & Flor, 1999). Nociceptive pain is
defined as being caused by actual damage to the somatic tissues, but no neural tissue or cells
(Keene et al., 2011). When pain persists beyond actual nociceptive input, dysfunction results and
the nociceptor(s) are considered to have lost their physiological function and considered to be
operating in a maladaptive way (Ruscheweyh, Wilder-Smith, Drdla, Liu, & Sandkuhler, 2011).
Specifically, pain that persists after the healing of an injury is thought to occur due to
dysfunctional nociceptors resulting in an alteration of nociceptive input to the central nervous
system (Ruscheweyh et al., 2011). Some examples of nociceptive pain include sprains, burns,
cuts, muscular tears or strains, bruises, and inflammation (Chapman et al., 1999). Nociceptive
pain is time-limited, localized, and is usually constant and of a throbbing, dull, or aching nature
(Chapman et al., 1999). Typically, nociceptive pain is highly responsive to treatment with opiate
pain medications (Aiello-Laws, Reynolds, Deizer, Peterson, & Bakitas, 2009).
Neuropathic pain. Neuropathic pain is the malfunction of the nervous system when
actual damage has previously occurred; it is considered chronic in nature (Beith, Kemp, Kenyon,
Prout & Chestnut, 2011; Chapman et al., 1999). Generally, neuropathic pain involves some
damage to either the central or peripheral nervous system, negatively affecting sensation (Beard
& Aldington, 2011; Harris, 2011; Keene et al., 2011). The pain has been found to persist beyond
when the injured area has healed, leading to persistent allodynia (i.e., pain that is elicited by a
stimulus that does not typically elicit pain), which is indicative of a malfunctioning nervous
system and false alarms (Beard & Aldington, 2011; Turk & Flor, 1999). Examples of
neuropathic pain include phantom limb pain, post herpetic neuralgia, and carpel tunnel syndrome
(Beard & Aldington, 2011; Harris, 2011). Neuropathic pain has been described as having a
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burning, shooting, tingling, or electric quality along with numbness and is of a more chronic
nature, lasting numerous months or even years (Beard & Aldington, 2011; Chapman et al.,
1999). In addition, neuropathic pain is less responsive to opiate pain medications and typically is
not fully reversible (Polatin & Gajraj, 2002). Neuropathic pain, however, has been found to be
responsive to other pharmaceuticals, such as psychotropic medications (i.e., anti-depressants and
anti-seizure medications) (Aiello-Laws et al., 2009; Robinson, 2007; Winteridge, 2009).
Conceptualization of Anxiety, Fear, and Pain
Although the Fear-Avoidance Model highlights fear specifically, it also can connect fear,
anxiety, and depression to pain. In this model, the initial experience of pain is viewed by the
individual as catastrophic regardless of its actual intensity (Bailey et al., 2010). For the small
portion of individuals that appraise the experience of pain as devastating, catastrophic cognitions
relating to the painful experience will develop and negative significance will be attached to the
experience of pain and any stimuli associated with the painful experience (Bailey et al., 2010).
The presence of catastrophic cognitions and negative significance will then lead to the individual
developing what was previously mentioned as fear of pain (Bailey et al., 2010). The experience
and maintenance of fear of pain and faulty evaluations or appraisals of the situation increases the
chances of developing safety-seeking behaviors such as avoidance and escape behaviors as well
increasing one’s awareness of the environment and one’s somatic and psychological state
(Asmundson, Norton, & Velso, 1999; Bailey et al., 2010; Leeuw et al., 2006).
Fear of pain can be adaptive in cases of acute pain, but generally is maladaptive for the
experience of chronic pain (De Peuter et al., 2009; Leeuw et al., 2006). The cycle of
avoidance/escape behaviors as well as hypervigiliance prevents or decreases pain experienced in
the short-term and thus is self-maintained through negative reinforcement. The formation of this
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negative, self-maintaining cycle actually exacerbates the experience of pain especially when an
injured area has already healed (Asmundson et al., 1999; Keogh & Mansoor, 2001). Further,
avoidance/escape behaviors function to reduce fear in the immediate future whereas in the longterm, these behaviors actually increase the fear associated with potentially painful experiences
(Leeuw et al., 2006). Other associated outcomes with this fear-avoidance cycle in relation to the
experience of pain are weight gain, muscular atrophy, and decreased mobility (Asmundson et al.,
1999). Although this model focuses specifically on fear and pain, the Fear-Avoidance Model
also is applicable to depression and anxiety (Bailey et al., 2010; De Peuter et al., 2009). The
interaction of fear and avoidance in relation to pain exacerbates the experience of pain, which in
turn negatively affects the development and maintenance of anxiety and depression (Bailey et al.,
2010; De Peuter et al., 2009).
Relation between Pain and Emotions
A major component of the experience of pain is emotional distress (Linton & Shaw,
2011). The relation between pain and emotion is thought to be associated through shared neural
connections and activation of the limbic system, specifically the amygdala, through the medial
pain system (Linton & Shaw, 2011; Roy, Piche, Chen, Peretz, & Rainville, 2009). During the
experience of pain, the medial pain system is thought to activate the hippocampus, which may
account for the ease of recalling such painful experiences and ultimately, leading to greater
escape and avoidance behaviors (Lumley et al., 2011). In addition to activation of similar cortical
regions, pain is believed to activate similar pathways that also are associated with the experience
of negative emotions (Mitchell & Harrison, 2010). Further, emotion and pain are thought to
affect similar physiological arousal systems including cardiovascular, visual, somatosensory, and
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auditory systems (Mitchell & arrison, 2010). Emotion also affects individuals’ cognitions and
behaviors in relation the experience of pain (Lumley et al., 2011).
The functional or evolutionary purpose of emotion associated with pain is to increase
awareness and to initiate adaptive behaviors (Lumley et al., 2011). The affective-motivational
system that is associated with the experience of pain and emotion is thought to be related to
activation of defensive behaviors like avoidance and escape to cope with the experience of pain
(Lumley et al., 2011). Researchers have found that maladaptive coping strategies associated with
emotion and negative affect are related to pain and dysfunction (Lumley et al., 2011). Negative
affect, in particular, has been found to be associated with increased suffering associated with
painful conditions as well as greater disability and poorer treatment outcomes for individuals
who suffer from painful conditions (Linton & Shaw, 2011; Roy et al., 2009).
In contrast to negative emotional states, positive emotional states have been found to lead
to a reduction of pain and better coping strategies (Lumley et al., 2011; Roy et al., 2009).
Deficits in emotional awareness may lead to hypervigilance of one’s physical being as well as an
increase in one’s physical sensations, inclusive of the experience of pain (Lumley et al., 2011).
The experience of pain also may lead to deficits in emotional functioning (Lumley et al., 2011).
In fact, in one study, individuals when exposed to painful stimuli were unable to distinguish
between positive and negative affect (Lumley et al., 2011). Ambivalence of emotional
expression, “the desire to express emotion, yet the fear of doing so,” leads to greater experiences
of pain and poorer quality of life (Lumley et al., 2011, p. 950).
In light of these findings, negative emotional states are thought to exacerbate pain
primarily in situations in which the individual is highly aroused by the painful experience
(Lumley et al., 2011). This phenomenon, however, may also be conceptualized as a bi-
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directional interaction between emotion and pain in which pain also can negatively influence an
individual’s emotional state. The suppression of emotion, specifically anger, is associated with
the exacerbation of the experience of pain, heightened pain sensitivity, lower pain tolerance,
(Lumley et al., 2011; Quartana, Bounds, Yoon, Goodin, & Burns, 2010). It is believed that
negative affect may play a role in the relationship between suppression of emotion (e.g., anger)
and the experience of pain (Quartana et al., 2010). In reference to the interaction of emotions and
pain, some of the most common emotional reactions that are highly associated with experience
of pain are depression, anxiety, fear, guilt, anger, and frustration (Linton & Shaw, 2011).
Fear
In relation to pain, fear is a multidimensional state that is a complex composition of
catastrophizing about bodily cues, fear of re-injury, and beliefs that avoidance/escape behaviors
of potentially painful experiences will prevent the experience of pain in the future (Karoly et al.,
2008). Others have defined fear as a “mobilization for avoidance/escape and other responses”
(McNeil & Rainwater, 1998, p. 390). Fear of pain, more specifically, is defined as “…an
excessive, irrational, and debilitating fear of physical movement and activity, resulting in fears of
vulnerability to painful injury or (re)injury” (Reneman, Schiphorts, Kleen, Geertzen, & Dijkstra,
2007, p. 248). Fear is a component of the fight or flight response of the autonomic nervous
system which is activated when a threat is detected (Craske, 2003). Fear, a more immediate
response to the experience of pain, occurs in close proximity of the actual experience of pain and
leads to avoidance and escape behaviors (Bailey et al., 2009; Craske, 2003). Fear functions as a
protective state from actual or potential threats through the development of avoidance behaviors
which leads to improved survival (Craske, 2003). Due to the automatic nature of the fear
response, there is a limited depth of cognitive processing that occurs when fear is initially
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activated, which decreases higher level cognitive processes such as judgment (Craske, 2003).
Due to the lack of advanced cognitive processes, fear, originally an adaptive mechanism, can be
incorporated in the development and maintenance of pain (Dehghani, Sharpe, & Nicholas, 2010;
Vowles, McNeil, Sorrell, & Lawrence, 2006).
The development of pain-related fear can develop through the actual experience of pain
(Bailey et al., 2009). Fear of re-injury or exacerbation of the sensation of pain that is associated
with the experience of chronic pain in particular can be quite debilitating, leading to avoidance of
normal activities such as work and enjoyable hobbies (Gatchel & Dersch, 2002; Karoly et al.,
2008; Robinson, 2007). Individuals who have high levels of fear also are more likely to overpredict future painful experiences, report greater intensities of pain, and perceive greater
disability associated with pain (De Peuter et al., 2009). High levels of fear also have been found
to be associated with decreased physical performance on tasks, decreased participation in
activities, and poorer treatment performance (Asmundson et al., 1999; De Peuter et al., 2009).
Pain catastrophizing
A central component in the development of fear of pain may be the catastrophizing
cognitions associated with the occurrence of pain (De Peuter et al., 2009). The cognitive
phenomenon of pain catastrophizing is a component of fear of pain and has been found to be
associated with increased reports of pain, use of pain medication, pain related distress and
disability (Dehghani et al., 2010; De Peuter et al., 2009). Pain catastrophizing has been found to
be related to the intensity of pain for individuals suffering from acute pain conditions (Gilliam et
al., 2010). For chronic pain suffers, pain catastrophizing has been found to negatively influence
the severity of the experience of pain, adjustment, and emotional distress associated with pain
(Gilliam et al., 2010). Further, individuals who are classified as high pain catastrophizers are
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more likely to attempt to suppress their emotions and awareness of pain due to the overwhelming
nature of the experience of pain, which ultimately leads to an exacerbation of the experience of
pain and delays recovery (Gilliam et al., 2009).
Pain catastrophizing also has been found to be a significant risk factor for suicide ideation
(Fishbain et al., 2009a). Catastrophizing cognitions also are significant component in the
development of fear of re-injury, another component of fear of pain (De Peuter et al., 2009). The
compounded effect of pain-related fear and cognitive catastrophizing can lead to the
development of avoidance and escape behaviors from tasks that are appraised as potentially
painful, resulting in overall distress and poor outcomes (Karoly et al., 2008; Leeuw et al., 2007;
Lumley et al., 2011; Reneman et al., 2007). Hypervigilance, an acute awareness of one’s
physical and psychological state, can compound the relation between pain catastrophizing
cognitions and reported pain, making avoidance behaviors more likely (Leeuw et al., 2007;
Reneman et al., 2007). Hypervigilance also can lead to negative effects on individuals who
suffer from pain (Leeuw et al., 2007; Reneman et al., 2007). Hypervigilance is a top-down
process which is automatic in nature and limits ability to cope with the experience of pain in
more effective ways (De Peuter et al., 2009). Also, the greater the experience of pain, the more
likely the individual will become hypervigilant of somatic sensations (White et al., 2009).
Hypochondriasis
According to the Diagnostic and Statistical Manual of Mental Disorders-V (DSM-V),
hypochondriasis is composed of an intense fear and belief of having a serious disease or healthrelated problem that is based on a misinterpretation of bodily cues and persists after reassurance
from medical professionals (American Psychiatric Association, 2013). Health anxiety, also
known more formally as hypochondriasis, is a function of cognitive catastrophication of health
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and somatic information and cues (Rode, Salkovskis, Dowd, & Hanna, 2006). Chronic pain has
been found to be associated with hypochondriasis (Rode et al., 2006).
According to Glenton (2003), there appears to be concern (e.g., fear) among many back
pain sufferers about the degree to which medical staff and others question the legitimacy of their
pain. The difficulty in determining the cause of back pain can make circumstances generally
more challenging for suffers of chronic back pain (Glenton, 2003). When the cause of pain is
more difficult to diagnose, individuals suffering from pain will seek assistance from health
professionals to determine an organic cause of the pain (Glenton, 2003).
Individuals suffering from back pain in which the cause of the pain is difficult to
determine are less likely to accept psychological explanations of their pain (Glenton, 2003).
Their unwillingness to accept psychological causes of their pain may be attributable to the
potential stigma that may be attached to them if the cause of the pain is found to be
predominately or solely psychological (Glenton, 2003). Visible proof (e.g., casts, crutches,
braces, etc.) of one’s ailments appears to assist in confirming one’s condition to others and thus
is reinforcing (Glenton, 2003).
Somatization is associated with multiple, frequent physical issues that have no medical
explanation and lead one to seek medical treatment (American Psychiatric Association, 2013).
Somatization, in contrast to hypochondriasis, requires more physiological or psychological
complaints that focus on one’s entire body.

ypochondriasis can be viewed by some as being

encompassed within a diagnosis of somatization (Fishbain, Lewis, Gao, Cole, & Rosomoff,
2009b; Lipowski, 1988). Somatization has been found to be highly associated with
hypochondriasis and chronic pain (Fishbain et al., 2009b). Pain intensity also appears to play a
significant role in the associations between chronic pain, somatization, and hypochondriasis
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(Fishbain et al., 2009b; Rode et al., 2009). In addition emotional states such as anxiety and
depression have been linked to chronic pain, somatization, and hypochondriasis (Fishbain et al.,
2009b; Lipowski, 1988).
Anxiety and Anxiety Sensitivity
Anxiety is one of the most studied psychological constructs associated with pain (Mok &
Lee, 2008). It is common to find anxiety present even when the onset of pain is fairly recent
(Cleeland, 1986). Studies have found a high degree of comorbidity between the experience of
pain and anxiety disorders such as generalized anxiety disorder, social anxiety disorder, posttraumatic stress disorder, and panic disorder (Asmundson & Katz, 2009; Beesdo et al., 2008).
Individuals who suffer from chronic pain are more likely to develop anxiety disorders than
individuals without pain (Linton & Shaw, 2011). Anxiety, in relation to the experience of
chronic pain, often is more of a diffuse, response to the experience of pain and can increase
withdrawal behaviors (Bailey et al., 2009; McNeil & Rainwater, 1998).
In general, there is usually a great deal of ambiguity in the conceptualizations of anxiety
and fear. These states often are confused, especially in reference to the experience of pain.
Although seemingly similar, fear or panic is qualitatively different from anxiety or worry
(Craske, 2003). In fact, they may even be mutually exclusive (Craske, 2003). Fear and anxiety
activate different response systems that are based on the imminence of the threat (Craske, 2003).
In contrast to fear, anxiety has been described as more of a diffuse reaction to future-oriented
events (Craske, 2003; Leeuw et al., 2007). More specifically, anxiety is a “diffuse reaction
pattern…[including]…responses such as worry that require less visceral organization and
activity” (McNeil & Rainwater, 1998, p. 390). Anxiety related to the experience of pain has been
found to be in anticipation of a nociceptive stimulation (Bailey et al., 2009). The purpose of
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anxiety is to prepare and plan for any potential threats (Craske, 2003). Anxiety functions as a
means of attempting to gain certainty and is associated with reduced autonomic arousal, lower
skin conductance, and heart rate variability (Craske, 2003). Anxiety also has been found to affect
the experience and maintenance of pain, disability associated with pain, and the chronicity of
pain (Mok & Lee, 2008). Anxiety can lead to greater perceptions of future painful experiences
and over-predictions of new experiences of pain (Bailey et al., 2010; Vadalouca et al., 2009).
Anxiety also is a predictor of pain intensity (Mok & Lee, 2008; Vadalouca et al., 2009). The
presence of anxiety and pain in addition to depression has been found to be associated with
greater disability, increased likelihood of substance use, and decreased quality of life (Beesdo et
al., 2008).
Research suggests chronic pain is associated with anxiety sensitivity (Uman, Stewart,
Watt, & Johnston, 2006). Anxiety sensitivity has been defined as the fear of anxiety-related
physiological and psychological arousal symptoms (Asmundson & Katz, 2009). Evidence
suggests that anxiety sensitivity may exacerbate the experience of pain (Stewart & Asmundson,
2006). It is believed that anxiety sensitivity and the experience of pain are connected through
higher levels involving body vigilance or hypervigilance (White, Craft, & Gervino, 2009).
Specifically, individuals with a high degree of anxiety sensitivity will be more likely to interpret
somatic symptoms, such as pain, negatively (Asmundson & Norton, 1995). In addition to high
degrees of body vigilance, individuals who experience high levels of anxiety sensitivity are more
likely to have increased avoidance and anxiety-related escape behaviors which can be
compounded further by the experience of pain (Asmundson & Taylor, 1996; Norton &
Asmundson, 2004). High anxiety sensitivity has also been found to be associated with greater
degrees of reported pain and cognitive anxiety leading to the development of pain-related
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catastrophizing cognitions and fearful appraisals of situations and stimuli (Watt, Stewart,
Lefaivre, & Uman, 2006). Factors that are strongly associated with anxiety sensitivity and pain
are fear of potentially painful experiences, greater avoidance behaviors, and greater sensitivity to
overall arousal symptoms are those which are more likely to lead to poorer outcomes for
individuals suffering from pain (Asmundson & Taylor, 1996; Watt et al., 2006).
Depression
Besides anxiety, depression is one of the most studied variables within the realm
of pain related research (Mok & Lee, 2008). Approximately 50 to 65 % of depressed individuals
suffer from comorbid pain conditions (DeVeaugh-Geiss et al., 2010; Poleshuck et al., 2010).
These same individuals present with more somatic than psychological complaints (DeVeaughGeiss et al., 2010; Poleshuck et al., 2010). In addition, approximately 21% of chronic pain
patients present with a comorbid diagnosis of depression (Schattner & Shahar, 2011). Chronic
pain has been found to be highly associated with the development of depression (Cleeland,
1986). Lerman, Shahar, and Rudich (2010) define depression as a complex composition of
somatic, cognitive, and affective constituents which results in sleep pattern changes, weight
change, negative affect, fatigue, loss of interest in activities, and interpersonal difficulties.
Depression has been found to affect both the chronicity and reoccurrence of pain (Mok & Lee,
2008). The comorbidity of pain and depression lead to decreased functionality, decreased quality
of life, poor interpersonal relationships, and over-utilization of health care (Ang et al., 2010;
DeVeaugh-Geiss et al., 2010; Poleshuck et al., 2010). Individuals with both depression and pain
are generally less responsive to various treatment methodologies, which can lead to poorer
outcomes in comparison to individuals suffering only from depression or pain (Ang et al., 2010;
Poleshuck et al., 2010; Schattner & Shahar, 2011). The magnitude of depressive symptoms in
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addition to the experience of pain is a significant predictor of suicidal ideation (Fishbain et al.,
2009a). When pain conditions are managed or treated effectively, comorbid depression
symptomatology typically improves, and can be dramatic (DeVeaugh-Geiss et al., 2010).
Some findings indicate that depression increases the chances of the development of pain-related
conditions whereas others indicate pain as the predisposing factor to the development and
maintenance of depression (Ang et al., 2010; Gatchel & Dersch, 2002). Like anxiety and fear, the
relation between pain and depression is complex and likely multi-directional. The specific
variables that account for the high degree of comorbidity of depression and pain are difficult to
tease apart (Cleeland, 1986; Lerman et al., 2010). Some researchers hypothesize that both
depression and pain share several factors, specifically affective and somatic components, which
may partially account for the relation (Harris, 2011; Lerman et al., 2010). Further, studies have
shown depression and pain share common neurological pathways (Lerman et al., 2010).
Conclusions
Pain can be viewed as an adaptive response in the short-term whereas over an extended
period of time, the response becomes maladaptive. Emotions have been found to be highly
related to the experience of pain. The conceptualizations of pain and emotion have evolved over
time with current theory emphasizing the multi-directional nature of their relations. Various
emotional conditions such as fear, anxiety, and depression have been found to be related to pain,
such that these emotional conditions can exacerbate the negative effects of the experience of
pain. This literature review highlights the importance of the consideration of emotion in addition
to the experience of pain.
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Appendix B
Letter to Expert Judges
October 4, 2012
Dear ______,
I am asking for your help with my Master’s thesis project. I am developing a 4 item assessment
which will be utilized in assessing anxiety, fear, depression, and overall negative affectivity in
relation to pain. Ultimately, I am hoping to identify a single item that can be used to assess
negative affect about pain. In order to evaluate the content of the assessment items early in
the developmental phase, an expert review process has been incorporated. I request that you
offer your opinion about the relevance of each of the items for measuring each construct in
relation to pain. This should be a relatively brief endeavor of 10-30 minutes, but your
professional judgment, comments, and suggestions would be of great benefit to me.
I am asking you to evaluate items that relate to anxiety, fear, and depression, as well as items
about negative affect in general. I want to add one brief note about the distinction between
anxiety and fear. Anxiety will be operationally defined as more of a diffuse reaction to futureoriented events whereas fear is operationally defined as a more immediate response to the
experience of pain and typically occurs in close proximity of the actual experience of pain.
Depression will be operationally defined as a complex composition of somatic, cognitive, and
affective components which can result in various negative effects (i.e., sleep pattern changes,
weight change, negative affect, fatigue, loss of interest in activities, and interpersonal
difficulties). The relationship between pain and these negative affective states is classified as
complex such that these negative affective states can exacerbate pain and pain can exacerbate
these negative affective states. The psychological variables mentioned above have been found
to negatively affect patient responses to pain treatment as well. Numerous assessments that
assess anxiety, fear, depression, or pain have already been developed. There is, however, a
paucity of measures which assess all of these constructs in one scale and even fewer that are
brief in length. Brevity of assessment is crucial in medical, dental, and clinical settings. The
ultimate goal of this study is to design a brief (i.e., 4 item scale) in which one item will be
utilized to assess each construct. This brief assessment will be useful in a variety of healthbased settings.
I am hoping that you would be willing to participate in the expert review. The attached
document titled “A Brief Assessment of Distress and Pain – Ratings by Expert Judges” provides
instructions and spaces for providing feedback both on individual items. The statistical analysis
only requires 8 experts to do ratings, so you are part of a select group, and your involvement
will be much appreciated. You can respond on paper or via e-mail, whichever is easier for you.
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In research such as this project, WVU’s institutional review board has deemed that an expert
review process is in itself not considered human subjects research, and hence is not subject to
IRB review or informed consent.
If possible, please respond in the next 2 weeks (October 18th). We are hoping to begin data
collection in the near future. Thank you very much for your time and consideration. If you have
any questions or concerns, please contact me at lquentin@mix.wvu.edu or my dissertation
chair, Dr. Daniel W. McNeil, at Daniel.McNeil@mail.wvu.edu. You also may send the completed
review to me at my e-mail address, or at PO Box 6040, Department of Psychology, West Virginia
University, Morgantown, WV 26506-6040 USA. Thank you again.
Sincerely,
Laura Quentin
Doctoral Student in Clinical Psychology
West Virginia University
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Appendix C
Fear of Pain Questionnaire-III (FPQ-III)
The items listed below describe painful experiences. Please look at each item and think about how FEARFUL you
are of experiencing the PAIN associated with each item. If you have never experienced the PAIN of a particular
item, please answer on the basis of how FEARFUL you expect you would be if you had such an experience. Fill in
one circle for each item below to rate your FEAR OF PAIN in relation to each event.
Not At
All

A Little

A Fair
Amount

Very
Much

Extreme

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

7. Hitting a sensitive bone in your elbow –
your “funny bone.”

○

○

○

○

○

8. Having a blood sample drawn with a
hypodermic needle.

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

○

13. Breaking your neck.

○

○

○

○

○

14. Receiving an injection in your
hip/buttocks.

○

○

○

○

○

15. Having a deep splinter in the sole of
your foot probed and removed with
tweezers.

○

○

○

○

○

1. Being in an automobile accident.
2. Biting your tongue while eating.
3. Breaking your arm.
4. Cutting your tongue licking an envelope.
5. Having a heavy object hit you in the head.

6. Breaking your leg.

9. Having someone slam a heavy car
on your hand.

door

10. Falling down a flight of concrete stairs.
11. Receiving an injection in your arm.
12. Burning your fingers with a match.
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Not At
All

A Little

A Fair
Amount

Very
Much

Extreme

16. Having an eye doctor remove a foreign
particle stuck in your eye.

○

○

○

○

○

17. Receiving an injection in your mouth.

○

○

○

○

○

18. Being burned on your face by a lit
cigarette.

○

○

○

○

○

19. Getting a paper-cut on your finger.

○

○

○

○

○

20. Receiving stitches in your lip.

○

○

○

○

○

21. Having a foot doctor remove a wart from
your foot with a sharp instrument.

○

○

○

○

○

22. Cutting yourself while shaving with a
sharp razor.

○

○

○

○

○

23. Gulping a hot drink before it has cooled.

○

○

○

○

○

24. Getting strong soap in both your eyes
while bathing or showering.

○

○

○

○

○

25. Having a terminal illness that causes you
daily pain.

○

○

○

○

○

26. Having a tooth pulled.

○

○

○

○

○

27. Vomiting repeatedly because of food
poisoning.

○

○

○

○

○

28. Having sand or dust blow into your eyes.

○

○

○

○

○

29. Having one of your teeth drilled.

○

○

○

○

○

○

○

○

○

○

30. Having a muscle cramp.

*Note. Item 10 was repeated at the end of the FPQ-III in the assessment battery.
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Appendix D
Pain Anxiety Symptoms Scale (PASS)

0

1

2

3

4

Never

5
Always

__

1. I think that if my pain gets too severe, it will never decrease.

__

2. My mind is calm when I am in pain.

__

3. When I feel pain I try to stay as still as possible.

__

4. I become sweaty when in pain.

__

5. When I feel pain, I am afraid something terrible will happen.

__

6. My thoughts are agitated and keyed up as pain approaches.

__

7. I go immediately to bed when I feel severe pain.

__

8. Even though it hurts, I know that I’m going to be O.K.

__

9. My body gets shaky when I hurt.

__

10. I feel disoriented and confused when I hurt.

__

11. When pain gets severe, I call my doctor or go to the emergency room.

__

12. I begin trembling when engaged in an activity that increases pain.

__

13. When I feel pain, I become afraid of dying.

__

14. I can’t think straight when in pain.

__

15. I will stop an activity as soon as I sense pain coming on.

__

16. Even if I do an activity which causes pain, I know it will decrease later.

__

17. Pain seems to cause my heart to pound or race.

__

18. I think that I have a serious medical problem that my physician has failed to
uncover.

__

19. As soon as pain comes on I take medication to reduce it.

__

20. I have pressure or tightness in my chest when in pain.
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0

1

2

3

4

Never

5
Always

__

21. When I feel pain I think that I might be seriously ill.

__

22. During painful episodes it is difficult for me to think of anything besides the
pain.

__

23. I avoid important activities when I hurt.

__

24. When I sense pain, I feel dizzy or faint.

__

25. Pain sensations are terrifying.

__

26. When I hurt, I think about the pain constantly.

__

27. I take medication if I know that I need to do something which usually
increases pain.

__

28. I have trouble catching my breath when I have pain sensations.

__

29. I dread feeling pain.

__

30. I am bothered by unwanted thoughts when I’m in pain.

__

31. If a chance comes to do something I enjoy, I do it even if it causes pain.

__

32. Pain makes me nauseous.

__

33. When pain comes on strong, I think that I might become paralyzed or more
disabled.

__

34. I find it hard to concentrate when I hurt.

__

35. I seek reassurance that I am OK during times of more severe pain.

__

36. I find it difficult to calm my body down after periods of pain.

__

37. I worry when I am in pain.

__

38. My stomach bothers me when I experience pain.

__

39. I try to avoid activities that cause pain.

__

40. I can think pretty clearly even while experiencing severe pain.
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Appendix E
Anxiety Sensitivity Index-3 (ASI-3)
Please circle the number that best corresponds to how much you agree with each item. If any
items concern something that you have never experienced (e.g., fainting in public) answer on the
basis of how you think you might feel if you had such an experience. Otherwise, answer all items
on the basis of your own experience. Be careful to circle only one number for each item and
please answer all items.
Very
Little

A little

Some

Much

Very
much

1. It is important for me not to appear
nervous.

0

1

2

3

4

2. When I cannot keep my mind on a
task, I worry that I might be going
crazy.

0

1

2

3

4

3. It scares me when my heart beats
rapidly.

0

1

2

3

4

4. When my stomach is upset, I worry
that I might be seriously ill.

0

1

2

3

4

5. It scares me when I am unable to
keep my mind on a task.

0

1

2

3

4

0

1

2

3

4

7. When my chest feels tight, I get
scared that I won’t be able to breathe
properly.

0

1

2

3

4

8. When I feel pain in my chest, I
worry that I am going to have a heart
attack.

0

1

2

3

4

9. I worry that other people will
notice my anxiety.

0

1

2

3

4

0

1

2

3

4

6. When I tremble in the presence of
others, I fear what people might think
of me.

10. hen I feel “spacey” or spaced
out I worry that I may be mentally ill.
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11. It scares me when I blush in front
of people.
12. When I notice my heart skipping a
beat, I worry that there is something
seriously wrong with me.
13. When I begin to sweat in a social
situation, I fear people will think
negatively of me.
14. When my thoughts seem to speed
up, I worry that I might be going
crazy.
15. When my throat feels tight, I
worry that I could choke to death.
16. When I have trouble thinking
clearly, I worry that there is
something wrong with me.
17. I think it would be horrible for me
to faint in public.
18. When my mind goes blank, I
worry there is something terribly
wrong with me.

Very
little

A little

Some

Much

Very
much

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4
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Appendix F
Tampa Scale for Kinesiophobia (TSK-11)
Instructions: These situations may or may not apply to you so you may wish to either select
disagree or strongly disagree. Other questions ask you about your beliefs so you may answer
them accordingly.
Strongly
Disagree
Agree
Strongly
Disagree
Agree
1. I’m afraid
that I might
injury myself if
I exercise.
2. If I were to
try to overcome
it, my pain
would increase.
3. My body is
telling me I have
something
dangerously
wrong.
4. People aren’t
taking my
medical
condition
seriously
enough.
5. My accident
has put my body
at risk for the
rest of my life.
6. Pain always
means I have
injured my body.

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4
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7.Simply being
careful that I do
not make any
unnecessary
movements is
the safest thing I
can do to
prevent my pain
from worsening.
8. I wouldn’t
have this much
pain if there
weren’t
something
potentially
dangerous going
on in my body.
9. Pain lets me
know when to
stop exercising
so that I don’t
injure myself.
10. I can’t do all
the things
normal people
do because it’s
too easy for me
to get injured.

11. No one
should have to
exercise when
he/she is in pain.

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1
1

2
2

3
3

*Note. Item 3 was repeated at the end of the TSK-11 in the assessment battery.

4
4
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Appendix G
Fear-Avoidance Beliefs Questionnaire (FABQ)
Instructions: Here are some of the things that patients with back pain have told us about their
pain. For each statement please circle the number from 0 to 6 to say how much physical activities
such as bending, lifting, walking, or driving would affect you if you had back pain.
0

1

2

Completely
Disagree

3

4

5

Unsure

6
Completely
Agree

1. My pain is caused by physical activity.
2. Physical activity makes my pain worse.
3. Physical activity might harm my back.
4. I should not do physical activities which (might) make my pain worse.
5. I cannot do physical activities which (might) make my pain worse.
The following statements are about how your normal work affects or would affect your back
pain:
6. My pain was caused by my work or by an accident at work.
7. My work aggravated my pain.
8. I have a claim for compensation for my pain.
9. My work is too heavy for me.
10. My work makes or would make my pain worse.
11. My work might harm my back.
12. I should not do my normal work with my present pain.
13. I cannot do my normal work with my present pain.
14. I cannot do my normal work till my pain is treated.
15. I do not think that I will be back to my normal work within 3 months.
16. I do not think that I will ever be able to go back to that work.
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Appendix H
Fear Questionnaire, Marks & Mathews - Agoraphobia Subscale (FQ-Ag)
Choose a number from the scale below to show how much you would avoid each of the
situations listed below because of fear or other unpleasant feelings. Then write the number you
chose in the space to the left of each situation.
0
1
Would not
avoid it

2
Slightly
avoid it

1. Travelling alone by bus or coach.
2. Walking alone in busy streets.
3. Going into crowded shops.
4. Going alone far from home.
5. Large open spaces.

3

4
5
6
Definitely
Markedly
avoid it
avoid it

7

8
Always
avoid it
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Appendix I
Demographics Form – Undergraduate Version
NAME:____________________ Today’s date:_________________
1. Age
How old are you?__________________________
2. Ethnicity / Race
What is your race or ethnicity?________________
3. Education Level
What is the highest level of education you completed?
_______________________________________
4. Romantic Relationship Status
Single (no current romantic partner)
Married/Live with current partner
Current partner lives outside the home
Separated / Divorced / Widowed
5. Current Employment Status
Full-time employment
Part-time employment
Unemployed
Disabled
Volunteer
Other: ___________________________

93
BRIEF ASSESSMENT OF DISTRESS AND PAIN
6. Current Occupation
Not applicable (N/A)
Student
Skilled trade
Unskilled trade
Homemaker
Professional (specify: ______________ )
Other: ___________________________
7. What is your (combined) annual household income (before taxes)?
8. Are you undergoing any current counseling or other outpatient treatment for emotional
or psychological problems?
Yes
No
9. Have you ever had any previous counseling or other outpatient treatment for emotional
or psychological problems?
Yes
No
10. Have you ever been hospitalized for emotional or psychological problems?
Yes
No
11. Are you currently taking any medications?
Yes

No

If “Yes”, please specify your medication(s) and dosage __# times taken per day here:
______________________________________________________________________________
______________________________________________________________________________
12. Do you have any current or past significant medical conditions?
Yes

No

If “Yes”, please specify your significant current or past medical condition(s) here:
______________________________________________________________________________
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13. What is your (combined) annual household income (before taxes)?
$0-20,000
$20-40,000
$40-60,000
$60-80,000
$80-100,000
$100,000
P1) YES NO

Do you now have significant pain that has lasted 6 months or more?

If NO, skip to P2
How severe would you rate that pain, on a scale from 0 – 100 with
0 being “no pain” and 100 being “the maximum pain
possible”?______

How long has this pain lasted?_______ (convert to months)

How many days a week do you experience this pain?____

What is the source of this pain?___________________________

Do you have any other significant pain now that has lasted 6 months or more? (Ask
the same follow up questions, and repeat this cycle until the participant reports no more
current chronic pain, then move to P2) ________________________________________
________________________________________________________________________
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P2) YES NO

(Besides any pain just discussed) Have you ever had significant pain

If NO, skip to P3 lasting 6 months or more?

How severe would you rate this pain, on a scale from 0 – 100, with 0
being “no pain” and 100 being “the maximum pain possible”?_______

How long did this pain last?______ (convert to months)

How many days a week did you experience this pain?_____

What was the source of this pain?____________________________

Have you had any other significant pain that has lasted 6 months or more? (Ask the
same follow up questions, and repeat this cycle until the participant reports no more past
chronic pain, then move to P3) ______________________________________________
________________________________________________________________________

P3) YES NO

Do you now have significant pain that has lasted less than 6 months?

If NO, skip to P4
How severe would you rate that pain, on a scale from 0 – 100 with 0
being “no pain” and 100 being “the maximum pain possible”?______

How long has this pain lasted?______ (convert to weeks)

How many days a week do you experience this pain?____

What is the source of this pain?___________________________
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Do you have any other significant pain now that has lasted less than 6 months? (Ask
the same follow up questions, and repeat this cycle until the participant reports no more
current acute pain, then move to P4)
___________________________________________________
__________________________________________________________________________

P4) YES NO

(Besides any pain just discussed) Have you ever had significant pain

If NO, skip to

lasting less than 6 months?

MED question
How severe would you rate this pain, on a scale from 0 – 100, with 0
being “no pain” and 100 being “the maximum pain
possible”?_______

How long did this pain last? ________ (convert to weeks)

How many days a week did you experience this pain?____________

What was the source of this pain?____________________________

Have you had any other significant pain that has lasted less than 6 months? (Ask the
same follow up questions, and repeat this cycle until the participant reports no more past
acute pain, then move to MED question)
_______________________________________________________________________
_______________________________________________________________________
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Appendix J
Demographics Form – Pain Sample Version
Participant ID #:____________________________________ Date:_______________________
1. Age: _______________
2. Sex (circle)
Male
Female
2. Ethnicity / Race (circle)
Caucasian/White
African-American/Black
Hispanic/Latino
Asian-American
American Indian/Alaskan Native
Other
Mixed
If answered you OTHER or MIXED, please describe.
________________________________________________________________________
3. Educational Level
How many years of formal education have you completed? (High school = 12 years;
4 year Bachelor’s college degree = 16 years, etc.)
____________
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4. Marital / Relationship Status (circle)
Single (no current romantic partner)
Married/Live with current partner
Current partner lives outside the home
Separated
Divorced
Widowed
5. Current Employment Status (circle)
Full-time employment
Part-time employment
Unemployed
Disabled, not working
Volunteer
Other: (describe: ___________________________ )
6. Occupation (either current, or the type of job you have had most of your life) (circle)
Student
Skilled trade
Unskilled trade
Homemaker
Professional (specify: ______________________ )
Other: (specify: ___________________________ )
7. What is the combined annual income for everyone living in your household (before
taxes)? (circle)
$0-20,000
$20-40,000
$40-60,000
$60-80,000
$80-100,000
$100,000 or more
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8. Are you undergoing any current counseling or other outpatient treatment for emotional
or psychological problems? (circle)
Yes

No

9. Have you ever had any previous counseling or other outpatient treatment for emotional
or psychological problems? (circle)
Yes

No

10. Have you ever been hospitalized for emotional or psychological problems? (circle)
Yes

No

11. In general, would you say your health is: (circle)
Excellent
1

Very Good
2

Good
3

Fair
4

Poor
5

12. Are you currently taking any medications? (circle)
Yes

No

If “Yes”, please specify your medication(s) and dosage __# times taken per day here:
Medication

Dose

# Times per Day
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13. Do you have any current or past significant medical conditions?
Yes

No

If “Yes”, please specify your significant current or past medical condition(s) here:
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
14. Have you ever had significant pain that has lasted 6 months or more? (circle)
Yes

No

If “Yes”, are you experiencing that pain now? (circle)
Yes

No

If “Yes”, how severe would you rate that pain, on a scale from 0 – 100 with 0 being
“no pain” and 100 being “the maximum pain possible”?
________________
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How long has the pain lasted?
_______________________ years
_______________________ months
How many days a week do you (or did you) experience this pain? (circle)
0
1
2
3
4
5
6
7
What is the cause of the pain?
________________________________________________________________________

15. Have you ever had significant pain that has lasted less than 6 months? (circle)
Yes

No

If “Yes”, are you experiencing that pain now? (circle)
Yes

No

If “Yes”, how severe would you rate that pain, on a scale from 0 – 100 with 0 being
“no pain” and 100 being “the maximum pain possible”?
________________

How long has the pain lasted?
_______________________ months
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How many days a week do you (or did you) experience this pain? (circle)
0
1
2
3
4
5
6
7
What is the cause of the pain?
________________________________________________________________________
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Appendix K
Additional Reliability Items – Undergraduate Sample
1. To show that you are reading this item, please select the second response option below.
Never
Sometimes
Occasionally
Always
*Appeared after the FPQ-III
2. Please select strongly disagree from the listed answer options. (Validity Item)
Strongly disagree
Disagree
Agree
Strongly Agree
*Appeared after the ASI-3
3. Please enter the following code into the answer box: Xq3F5jL
*Appeared after the FABQ

*Note. Item 3 was shown to not be effective in discriminating among consistent and inconsistent
responses thus was not utilized for determination of reliability for the undergraduate sample.

